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Abstract
Mutational Analysis and Domain Characterization of the Apolipoprotein L-1 Ion Channel
by
Charles Michael Schaub

Advisor: Dr. Jayne Raper

The human innate immunity factor Apolipoprotein L-1 (APOL1) protects against
Trypanosoma brucei brucei infection. Recent studies have shown recombinant APOL1
(rAPOL1) inserts into planar lipid bilayers at an acidic pH 5.6 and forms a cation-selective
channel, which opens upon subsequent neutralization, pH 7.2. This corresponds with the pH
changes APOL1 would encounter during endosome recycling, suggesting that APOL1 forms a
pH-gated ion channel in the plasma membrane of the parasite, leading to uncontrolled ion flux
and osmotic imbalance. However, structural and domain characteristics of the APOL1 channel
are poorly understood, despite potential similarities to diphtheria and colicin toxins. Utilizing E.
coli-derived rAPOL1, we tested the effect of numerous site-directed substitutions on channel
properties in planar lipid bilayers and in trypanoltyic assays. With this approach, we revealed
that a single residue in the C-terminus, aspartate-348, influences channel selectivity and pH
gating. Furthermore, we hypothesized that the C-terminal heptad repeat motif is required for
oligomerization and channel formation. Indeed, specific amino acid substitutions in this domain
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inhibit both channel formation and APOL1 mediated-trypanolysis. We then employed a scanning
cysteine accessibility approach to elucidate membrane topology and transmembrane domains of
the APOL1 channel. Taken together, these results highlight the importance of the C-terminus in
APOL1 function, and lend constraints for possible structures of the functional channel.
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Background
The APOL gene family
The Apolipoprotein L 1-6 (APOL1-6) gene family is a cluster of rapidly evolving
homologous proteins found in humans and other higher primates [1]. Located on a 619kD region
on chromosome 22, they arose from a gene duplication event in primates approximately 33
million years ago [2]. APOLs are all predicted to contain a Bcl-2 homology 3 (BH-3) domain,
and thus could potentially lead to programmed cell death (PCD) pathways [3, 4]. Indeed,
overexpression of APOL6 in HEK293 cells resulted in apopotosis of cancer cell lines [3]. The
APOL proteins are also up regulated by the pro-inflammatory signaling molecules interferonalpha, interferon-beta, interferon-gamma and tumor necrosis factor, and have been under heavy
positive selection during evolution [5-8]. Based on this evidence, the APOL family of proteins
would appear to be innate immunity factors. In support of this notion, APOL6 has been indicted
as a factor against Poliovirus, while APOL1 has been linked to ameliorating HIV infection in
HEK293 cells and Leishmania sp. [9-12]The best-studied and understood example, however, is
APOL1’s capacity to lyse African Trypanosomes both in vivo and in vitro [13-15]. However,
studies propose the trypanolytic mechanism of APOL1 is dependent on its ability to form cation
selective channels in biological membranes, as opposed to directly activating any PCD
pathways[16].

African Trypanosomes
African Trypanosomiasis is caused by the unicellular, flagellated parasites of the genus
Trypanosoma, and presents both an economic and health burden to sub-Saharan Africa.
Transmitted by the bite of an infected tsetse fly (glossina sp), the kinetoplastid has a complex
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two-stage life cycle between its vertebrate hosts and invertebrate vector [17]. Although the
species T. congolense, T. brucei brucei, and T. vivax are all causes of Animal African
Trypanosomiasis (AAT), better known as nagana in cattle, T. congolense has been described as
the most pathogenic [18]. Of note, some ~3-5 million cattle die as a result of infection, leading to
an agricultural burden estimated to be ~$4 Billion USD annually [19]. However, only the subspecies T. brucei rhodesiense and T. brucei gambiense are responsible for Human Africa
Trypanosomiasis (HAT) in Eastern/southern and Western/Northern Africa, respectively [20]. At
this time, T. b. rhodesiense infection remains a larger burden for humans lending to the acuteness
of the infection and the large amount of wild/domestic animals acting as a reservoir[21].
Whereas improved awareness, diagnostic testing, and treatments has limited HAT by T. b.
gambiense infection in recent years [22, 23]. In all, some ~20 million Africans are at risk for
infection, with some ~20,000 cases occurring per year [24, 25].
As previously mentioned, African Trypanosomes have a multistep lifecycle alternating
between vector and host. The cycle initiates when a teneral tsetse fly takes its first blood meal
from a previously infected mammal [26](10). During breakdown of the blood within the midgut
of the tsetse fly, the trypanosomes subsequently transform into the procyclic state, where they
can begin to multiply through binary fission [27](11). It then traverses the length of the tsetse fly
until it reaches the salivary glands, but not before differentiating into the epimastigote form
[27](11). Now residing in the salivary glands, the parasite reproduces asexually to generate
additional epimastigotes while simultaneously differentiating into the mammalian infective, freeswimming metacyclic form [27](11). Upon taking a blood meal, the fly deposits the
trypanosomes into the tissues of the host, causing differentiating into the bloodstream form (BF)
[28](12). The BF is then free to replicate in both the blood and tissues spaces until reaching a
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defined concentration threshold due to a recently defined quorum sensing mechanism [28](12).
The parasites prepare to repeat their lifecycle by generating the stumpy induction factor
assortment of soluble molecules, which initiates transformation into the non-replicating stumpy
form to be taken up once again by a teneral tsetse fly [29].
The infective bloodstream form of the parasite is characterized by its long, slender shape
and flagellum that transverses the entire length of the parasite ends at the anterior end [30]. At
the posterior of the parasite resides the flagellar pocket, where the flagellum is anchored and all
endocytic events take place (Figure 1) [31]. Uptake in the parasite is extremely rapid and
efficient, as evidenced by the variable surface glycoprotein coat being recycled every 15
minutes. [32]. Near the flagellar pocket resides the cytoplasmic kinetoplasmid, of which the
parasite gets its class name (kinetoplastea), that houses small circular DNA plasmids encoding
for all the mitochondrial genes [31]. Notably, the parasite only has a single mitochondrion,
spanning the entire length of the organism; yet oddly glycolysis produces a majority of ATP
required for cellular functions. Here, the mitochondrion serves as a site for processes including
fatty acid synthesis and catabolism of amino acids for vital cellular processes [33, 34].
The most unique characteristic of the T. brucei parasite is the dense surface coat covering
the entire length of the parasite. The specialized protein is termed Variable Surface Glycoprotein
(VSG), and is GPI-anchored into the plasma membrane of the BF [35, 36]. Comprising nearly
20% of all the protein expressed by the parasite, VSG forms a homodimer on the cell surface and
presents a large antigenic target for circulating antibodies and other immune factors, while
simultaneously blocking access to the limited receptors also present on the cell surface [37]. Due
to their extraordinary rate of endocytosis, the parasites are rapidly able to clear any antibodies
adhering to their VSG coat [38]. Furthermore, T. brucei are able to switch their VSG coat to one
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expressed by one of 2000 unique genes by switching chromosome expression or by creating
novel, “mosaic” VSG proteins through recombination of VSG genes [39, 40]. In this way, the
Trypanosome can continually evade the adaptive immune system and successfully survive within
the host.

Trypanosome Lytic Factors
While African Trypanosomes can infect mammals, humans and other select primates
have a natural resistance to infection. In 1984, a group observed that treating T. b. brucei with
normal human serum (NHS) resulted in colloid osmotic swelling and eventual lysis in vitro [41].
Conversely, treating the parasites with an equivalent amount of rabbit serum had no effect on
their growth or morphology. The authors then noted that supplementing the media with 0.25 M
sucrose prevented the osmotic swelling and lysis of the trypanosomes when treated with NHS,
potentially due to counterbalancing osmotic pressure within the parasite. Thus, further
suggesting trypanolysis is owing to unregulated ion flux across the membrane leading to an
influx of water and cell swelling. Previously, the trypanocidal factor was identified as the highdensity lipoprotein (HDL) fraction of human serum, although the mechanism of lysis was
untested [42]. Additionally, it was later determined subset of HDL with a molecular weight of
approximately ~500 kD was indeed the Trypanosome lytic factor (TLF) of human serum [43].
The TLF complex comprises approximately 1% of total HDL, and exists as two forms in
serum: TLF-1 and TLF-2 [43, 44]. The TLF-1 complexes is comprised of Apolipoprotein A-1
(APOA-1), Haptoglobin Related Protein (HPR), Hemoglobin (Hb), Apolipoprotein L-1 (APOL1)
and is approximately ~500kD in size, whereas the TLF-2 complex further incorporates an
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Immunoglobulin-M (IgM) molecule potentially bound to Hpr, and is therefore ~1000 kD in size
(Figure 2) [44]. The APOA-1 protein is primarily an amphipathic protein, and is able to form
multimers with the purpose of acting as the structural scaffold of the HDL [45, 46]. The HPR
and Hb proteins act as co-ligands for receptor- mediated endocytosis of TLF via the
Trypanosoma brucei Haptoglobin Receptor (HpHbTbR) [47]. HPR arose from gene duplication
of haptoglobin (Hp), which is normally complexed with Hb in blood and scavenged by the
CD163 receptor on macrophages [48]. However, HPR has a four amino acid mutation in the loop
recognized by CD163 and will therefore not be cleared from the blood [49]. This could serve a
dual purpose: The lytic ability of TLF will not affect the macrophages and the TLF remains in
the blood to continue its innate immune functions. The Apolipoprotein L-1 (APOL1) molecule is
the main lytic component of human serum, and has recently been shown to be a pH-gated cation
channel [13, 16].

Trypanolysis by TLF
African Trypanosomes are heme auxotrophs, and therefore must scavenge free heme
from the blood to survive [50]. The TLF-1 complex, specifically the Hpr-Hb co-ligands, are
thought to hijack this receptor, allowing for receptor-mediated endocytosis of TLF-1 at the
flagellar pocket. [47]. Despite these findings, evidence suggests TLF-2 is the main lytic
component of human serum. In vitro, adding physiological amounts of Hp to trypanolytic assays
blocked killing by TLF-1, but not TLF-2 [44], suggesting Hp, which is typically at a 50-100
higher fold concentration than Hpr in the blood, is able to out-compete TLF-1 for the receptor
and thus limit receptor-mediated endocytosis [51]. To explain this result, it has been
hypothesized that TLF-2 can bind to the VSG coat of the parasite, which then acts as a molecular
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sail to concentrate the complex in the flageller pocket for fluid phase endocytosis [38].
Thisalternate route of entry implicates TLF-2, that may have a greater relevance to humans
immunity to T. b. brucei than TLF-1.
As detailed above, trypanolysis is dependent on the endocytosis of the entire TLF
complex. [52].. Once endocytosed, the TLF was thought to traffic to the lysosome, where it
becomes activated in the acidic environment (Figure 3). There, it leads to disruption of the
lysosome, potentially due to APOL1 forming ion pores in the membrane [53-55]. In support of
this model, the weak base ammonium chloride has been observed to inhibit TLF-mediated lysis
due to neutralization of acidic compartments, thus preventing activation of APOL1 [56]. A
second proposed model for TLF-mediated lysis is due to the generation of oxygen free radicals
catalyzed by Hpr-Hb [57]. The free radicals then lead to peroxidation of lipids and lysosomal
membrane disruption [51, 58]. However, this model is likely incorrect because human serum
lacking Hpr retained lytic activity, albeit slightly delayed. Conversely, human serum from
individuals lacking the APOL1 gene was completely devoid of any trypanolytic activity, which
could be restored by supplementation recombinant APOL1 (rAPOL1) [59].
Treatment of trypanosomes with TLF leads to ion flux across the plasma membrane,
similar to what was observed by Rifkin [41]. In particular, it is understood treatment with TLF
leads to the influx of Na+ ions down their electrochemical potential gradient, followed by influx
of Cl- ions into the cytoplasm of the parasite [55]. Due to the increase in osmotic potential within
the parasite, excess water enters the cell resulting in swelling and eventual lysis. In support of
this sequence of events, pre-incubation of T. b. brucei with TLF in vitro could only be delayed,
but not rescued, by the replacement of Cl- with the larger, but still negatively charged gluconate-
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ion. Conversely, replacement of Na+ with the larger choline+ ion had to coincide with the
addition of TLF to prolong trypanolysis [55]. Additionally, treatment with 4,4’diisothiocyanatostilbene-2,2’-disulfonic acid (DIDS), a general chloride channel blocker, is able
to delay extracellular chloride influx after incubation with NHS [15]. Therefore, it would appear
Na+ influx precedes Cl- influx, which could be explained by APOL1 channels at the cell surface.
As mentioned earlier, the lytic component of TLF is the channel forming protein APOL1.
This was first established when NHS was run on an anti-APOL1 affinity column, and
successively testing the unbound sample in a trypanoltyic assay [13]. Unsurprisingly, it resulted
in complete loss of activity in vitro. However, combining the elutant from the anti-APOL1
column with the flow through restored trypanolytic activity [13]. Furthermore, adding back NHS
devoid of APOL1 with recombinant APOL1 (rAPOL1) purified from Chinese Hamster Ovary
(CHO) cells again restored lytic activity. Numerous other groups have confirmed this
observation, as rAPOL1 from E. coli has been shown to traffic to the lysosome on its own and
lyse trypanosomes in vitro [15, 60]. In addition, in vivo experiments testing mice transiently
expressing the APOL1 protein via hydrodynamic gene delivery become immune to trypanosome
infection [61]. Despite mounting research, the exact mechanism of APOL1-mediated lysis is
unclear, and this motivated us to determine if the channel forming properties are directly
involved.

Function of Apolipoprotein L-1
Located on a 14.5kD segment of chromosome 22q13, the gene encodes for six
introns and seven exons, resulting in the ~42kD protein [62]. The most common splice isoform,
variant A, includes the signal peptide (exons 1, 3-4; 1-33), a domain of unknown function (exon
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5-6; 35-105), while the remainder of the protein is coded in exons 6 and 7 (106-398) [63]. The
signal peptide would allow for cellular trafficking through the endoplasmic reticulum (ER),
leading to secretion of the protein and lending to the fact APOL1 is found on circulating HDL in
the serum. While nearly 95% of all secreted APOL1 comes from the liver, numerous other
tissues, including the neurons, intestines and kidneys, express basal levels of the mRNA
transcript [1, 8, 64]. However, pro-inflammatory cytokines, including interferon-gamma and
tumor necrosis factor, can result in a temporary up regulation of APOL1 [2]. Currently, the most
well defined function studied for APOL1 is its ability to lyse African trypanosomes both in vivo
and in vitro. Additionally, TLF has been shown to ameliorate Leishmania sp infection in
humans, but it is currently unclear if this is a similar or different mechanism than with the
Trypanosome sp. [11].
The trypanolytic activity of APOL1 can be attributed to its ability to form ion channels in
lipid membranes. Under acidic conditions, rAPOL1 has demonstrated spontaneous insertion into
both planar lipid bilayers and lipid vesicles made up of asolectin with or without cholesterol [16,
65]. Within the bilayer system, this insertion resulted in relatively small conductance, which
could not be washed away by perfusion, suggesting the protein was fully integrated into the
membrane. Subsequent neutralization resulted in a large, ~3000-fold increase in the macroscopic
conductance, potentially due to stabilization of the open channel state [16]. Titrating the solution
back to pH 5.3 with HCl reduced the conductance back to pre-neutralization levels, which could
be restored by addition of KOH to raise the solution to pH 7.2. The effect of pH on channel
conductance was also observed in the lipid vesicle assays. When APOL1 was inserted into
phospholipid vesicles at acidic pH 5, the ion efflux drastically increased when the extracellular
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pH was raised to pH 7.0 [65]. Thus, the evidence presented here suggests APOL1 is indeed a pHgated ion channel, although the residue(s) responsible have yet to be determined.
The same groups also addressed the selectivity of the APOL1 channel, and determined
the channel to be selective for cations over anions. In order to test channel selectivity, Thomson
and Finkelstein added increasing amounts of KCl to the cis solution after formation of a large
macroscopic conductance, resulting in a cis/trans ion activity gradient (cis-closer to
experimenter; trans-further from experimenter). By measuring the reversal potential required to
zero ion flow, and comparing it to the theoretical Nernst potential, they determined rAPOL1
channels were ideally cation selective [16]. They repeated this same experiment, but with sodium
and chloride as the primary ions. Predictably, channels were ideally selective for sodium over
chloride with this setup. In agreement with this result, an earlier paper assessing conductance
caused by TLF at acidic pH detected cation selective ion movement across the membrane [55].
The ion flow was thought to be due to APOL1 on the TLF complex, however the cation
permeability was not ideal. But, the difference in cis solution pH or bilayer phospholipids could
account for this difference. The cation selectivity observed was then further supported in
experiments with lipid vesicles in an extracellular milieu devoid of KCl [65]. After insertion and
APOL1 channel formation, a chloride carrier (CI1) was added to the system to permit anion
counter flow. If APOL1 were chloride selective, the resulting positive charge build up inside the
vesicles would inhibit further ion efflux. Nevertheless, the authors detected a pH-dependent
chloride efflux in the system, suggesting APOL1 was potassium permeant [65]. But it should be
added the authors performed a chloride permease assay, in which case the potassium selective
valinomycin would facilitate cation counter flux in the event APOL1 was anion selective.
Interestingly, a large anion efflux from the vesicles was detected under these conditions.
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Therefore, it would be pertinent to test the effect of various cis and trans pH values on APOL1
ion channel selectivity.
Taking into account the pH-gating and cation selectivity of APOL1, Thomson and
Finkelstien offered a mechanism for APOL1 trypanolytic activity. They proposed that after
endocytosis of the TLF complex, APOL1 inserted into the endosomal membrane under acidic
conditions. At this point, the endocytic vesicle embedded with APOL1 could either traffic back
to the plasma membrane or to the lysosome, the latter resulting in potential protein degradation
by cathepsin-L [66, 67]. However, trafficking to the membrane could expose APOL1 to a neutral
pH, resulting in formation of cation- selective pores at the cell surface. The resulting influx of
sodium could result in membrane depolarization and chloride influx, causing osmotic swelling
and lysis.
A second model proposed implicates coupling of lysosomal and mitochondrial membrane
permeabilization as the primary mediator of T. b. brucei lysis by APOL1 [60]. It was
demonstrated that the TbKIFC1 kinesin trafficked rAPOL1 to the mitochondria, where it caused
mitochondrial fenestration and release of TbEndoG endonuclease causing laddering of DNA.
Additionally, rAPOL1 was observed to cause pores in the lysosome resulting in lysosomal
swelling and membrane permeabilization, in agreement with the first papers identifying APOL1
as the lytic component of TLF [13, 15, 60]. Despite this evidence, it should be noted an RNAi
knockdown screen implicated different pathways for rAPOL1 and NHS-mediated lysis. In the
case of rAPOL1, lysis was not affected by either p67 knockdown, or ICP and TbCATL
depletion. Rather, NHS lytic activity was decreased in the first two conditions, and was increased
in the case of TbCATL [68]. Based on this evidence, rAPOL1 may participate in several unique
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death pathways, and all results with rAPOL1 should be recapitulated with NHS or TLF to
corroborate findings.

Molecular Arms Race
Despite humans having TLF, and more precisely APOL1, we can still become infected
with Trypanosoma brucei sp. In particular, the parasite T. brucei rhodesiense is able to
completely evade TLF- mediated trypanolysis due to the presence of a single gene, termed
Serum Resistance Associated factor (SRA) [69]. Notably, it has been shown to bind to the Cterminus of APOL1 at acidic pH, thus preventing TLF-mediated lysis [14, 70, 71]. The SRA
protein is a truncated homolog of the VSG gene, and is primarily localized to the endocytic
pathway; with small amounts localizing to the flagellar pocket [13, 52, 72]. The protein structure
is made up primarily of alpha helices, with the N-terminal transmembrane (TM) domains 1 and 2
forming an anti-parallel coiled-coil. However, the third helix blocks the VSG dimerization
interface, thus the protein exists as a monomer in solution and conserves the SRA-APOL1
interaction site [73].
Although T. b. rhodesiense is able to resist TLF lysis, T. b. gambiense is the species
responsible for a majority of all HAT cases in Sub-Saharan Africa [22]. Currently, the
mechanism of resistance to TLF by T. b. gambiense has yet to be elucidated, but several essential
genes have been identified. The first of which is a single amino acid mutation in the TbHpHbR
resulting in affinity loss for Hpr-Hb and therefore endocytosis of TLF [74]. However, we have
already illustrated the distinct uptake mechanism of TLF-2; which is independent of this
receptor, so it stands to reason this single mutation is only able to limit TLF-1 uptake into the
cell. A second gene essential for resistance is the Trypanosoma brucei gambiense Specific Gene
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(TgsGP), which is has been shown to stiffen membranes and resides in the endocytic pathway
[75, 76]. We then expect APOL1 would be inhibited from inserting into the endosomal
membrane at acidic pH, therefore limiting the number of APOL1 channels formed. But unlike
SRA, expression of this single gene is insufficient for resistance. Finally, the acidic pH of the
early endosome of T. brucei gambiense relative to other T. brucei sp. may allow for earlier
activation of cysteine proteases and therefore enhanced APOL1 degradation [75]. Taken
together, the resistance of T. b. gambiense to TLF appears to be multi-faceted, and dependent on
collaboration between multiple resistance mechanisms.
Possibly due to the evolution of these resistance mechanisms, there appears to be a
molecular arms race between human APOL1 and African trypanosomes. In the last ~10,000
years, two variants of APOL1 have arisen due to heavy positive selection [62]. The ancestral
haplotype, termed G0, is also the most common allele worldwide. The genetic variants, G1 and
G2, are defined by mutations in the C-terminal, SRA-interacting domain [77]. The G1 allele has
2 missense mutations, at S342G and I384M, while the G2 variant has a 6 nucleic acid deletion
resulting in deletion of N388/Y389. Both alleles confer resistance to T. brucei rhodesiense,
despite G1 having a higher binding affinity to SRA than G2 [14, 77]. Interestingly, the I384M
mutation lies in the SRA-APOL1-binding epitope, yet the S342G mutation confers partial
resistance, suggesting an alternate mode of evasion other than reduced binding affinity.
Conversely, the N388/Y389 deletion decreases binding affinity of APOL1 and SRA, thus
allowing for trypanolysis and channel formation [14, 77]. Thomson and Finkelstein later
supported this claim, and showed that pre-incubation of G0 rAPOL1 with rSRA had no effect on
membrane insertion, but prevented channel opening upon neutralization [16]. However, pre-
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incubation of the G2 rAPOL1 with SRA had no effect on channel formation and the protein was
able to still form a large macroscopic conductance.

APOL1 Domains and Structure
While APOL1 has been well characterized as a pH-gated, cation channel, the domains
lending to the functionality are currently unknown. The first paper characterizing the potential of
APOL1 to form pores termed residues 60-235 the pore-forming domain, due to its putative
structural similarity to pore-forming toxins as determined by the protein family motifs database
(Pfam) (Figure 4) [15, 78, 79]. A peptide consisting of only the pore-forming domain was
reconstituted in planar lipid bilayers, and an anion selective pore was observed at pH 5.5 [55].
Furthermore, when expressed in E.coli, the fragment could severely limit the colony-formation
units, whereas a peptide of APOL1 missing N-terminal residues 60-235 did not affect colony
growth[15]. Based on this evidence, the N-terminus has been deemed the pore forming domain
throughout the literature, despite inability to identify the selectivity filter or pore-lining region.
The region directly downstream of the supposed pore-forming domain, particularly
residues 238-304, has been regarded as the membrane-addressing domain (Figure 4). Modeling
of the region predicted it contained two amphipathic helices, suggesting it was capable of
forming stable hydrophobic interactions [15]. To confirm this in silico finding, a synthetic
peptide spanning amino acids L248-A291 was found to exhibit a high affinity for DOPC
monolayers, comparable to that of known lipid-interacting peptides [15, 80]. Supporting this
observation, compound substitutions of D249K/E253K/E256K prevented trypanolytic activity of
the full-length protein. Therefore, it was assumed the charged aspartate residues in this region
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interact with the choline head groups of the phospholipids in the endocytic pathway, promoting
APOL1 pore formation.
The C-terminus of APOL1 has conflicting reports in regards to function throughout the
literature. The first study that determined APOL1 was the lytic component of human serum
concluded the C-terminus was not necessary for Trypanoltyic activity. After depletion of APOL1
from NHS with SRA, an add back of a C-terminal truncation (del343-398) purified from CHO
cells was sufficient for lysis of trypanosomes sensitive to NHS [13]. In contrast to this finding,
planar lipid bilayer experiments of a truncated APOL1 lacking residues 341-398 were unable to
form any conductance at acidic pH or upon subsequent neutralization [16]. Additionally,
rAPOL1 deficient of the final nine amino acids did not have any effect on trypanolytic activity
[71]. Considering all this conflicting information, it is difficult to conclude the importance of the
C-terminus to channel formation and/or trypanolytic activity. The only consensus within the
literature is the C-terminus is the site of interaction with the SRA protein. Surface plasmon
resonance of C-terminal peptides of APOL1 showed strong binding to SRA at acidic conditions,
while numerous groups have reported pull-down of either SRA or APOL1 in coimmunoprecipitations [14, 71]. Taking into account SRA is solely responsible for inhibition of
APOL1- mediated trypanolysis of T. b. rhodesiense, it appears likely the C-terminus is necessary
for channel formation.
Despite the numerous studies on APOL1, minimal data concerning the structure has been
elucidated. In silico analysis of APOL1 secondary structure utilizing the PROFSec server
calculates three putative transmembrane domains and a coiled-coil in the C-terminus due to a
heptad repeat motif [14]. However, none of these transmembranes has been either confirmed or
discredited biochemically. Another group utilizing protein structure and function software
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yielded a potential three-dimensional model of the APOL1 channel. Employing the I-TASSER
online server and the known structures of various proteins, the APOL1 channel was predicted to
have five transmembrane domains, with residues S342, I384 and Y389 all involved in pore
formation [81]. Interestingly, these are the site-specific mutations found in G1 (amino acids
342/384) and G2 (amino acid 389). Notwithstanding, there is again no biochemical evidence
presented in this report or in the literature that supports this model.

Pore Formation of Bacterial Pore-Forming Toxins
The diphtheria toxin (DpTx) created by the gram-positive bacillus Corynebcaterium
diphtheria is able to form single channel cation conductance in planar lipid bilayers. Although
the full protein is 535 amino acids and made up of the C, T and R domains, only the T domain
has channel activity [82]. Additionally, only a 61 amino acid peptide of the T domain is required
for single channel conductances [79]. This fragment corresponds to transmembrane helicies 8
and 9 in the crystal structure, which forms an alpha helical hairpin, similarly predicted for
APOL1 [83]. The peptide is able to insert into the membrane at a cis acidic and trans neutral pH,
and the channel conductance is increased upon cis solution neutralization [84, 85]. These
conditions are similar to that required for the APOL1 channel, but the pH dependence of
conductance is not as stark. In addition, the 61 amino acid fragment contains three glutamate
residues near the pore, two of which are directly involved in channel conductance (D352 and
D362) [84, 86, 87]. Although the D362 residue lies within the pore itself, only the D352 residue
has a significant effect on ion selectivity. Furthermore, the D352 residue accounts for all of the
trans pH effect on conductance, implicating that the residue is located near or at the trans
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membrane [85]. Considering APOL1 also has three glutamate residues in the predicted hairpin
(177-228), it in our best interest to test if APOL1 has similar properties to that of DpTx.
Comparable to DpTx, the colicin Ia bactericidal protein is able to form voltagedependent, ion-conducting channels in lipid membranes [88]. A three-domain protein, only the
C-terminal channel-forming domain is necessary for ion conductance. Accordingly, a 40 amino
acid hydrophobic hairpin connected by a small loop within this region is responsible for
membrane association and insertion, which is especially favored at low pH [78]. The process
begins with the hairpin resting horizontally on the membrane surface, and the loop being
exposed to the cis solution. The hairpin can then spontaneously insert into the membrane,
although reversibly, exposing the loop to the trans solution. However, a cis positive voltage
(~50-70 mV) is required for translocation of a second segment necessary for ion conductance
[89]. While APOL1 does not exhibit any dependence on the voltage for ion conductance, the
membrane insertion of the hairpin and secondary fragment may be relevant to APOL1 channel
formation.

General Ion Channel Architecture
The general function of ion channels is to form a pore in biological membranes to allow
for the regulated passage of ions through the hydrophobic core of phospholipids down their
electrochemical potential. To accomplish this undertaking, ion channels have two basic
functions: to control the passage of select ions across a membrane, and to respond to specific
stimuli in the environment that shifts the channel between the open and closed states [90]. More
specifically, ion channels have conserved and/or typical selectivity filters that are able to
distinguish between cations or anions (ex: non-selective cation channels), and even between
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monovalent ions (ex: voltage-gated sodium or potassium channel) [91] [92]. Furthermore, the
channels can respond by either opening or closing to a range of inputs, including ligands,
voltage, temperature and even mechanical force. And opening of these channels permits up to
108-9 molecules/second to flux through the open pore [93]. While there are numerous classes of
these channels, the superfamily of voltage-gated potassium channels (VGKC) is one of the best
studied, and will be further focused on in order here to generate a better understanding of the ion
channel structure-function relationship.
Regarding the general architecture of the VGKC domains, they have three distinct
domain regions (Figure 5A). The first is the pore-forming domain, which consists of
transmembrane helices that span the length of the membrane. These helices form the pore itself,
and thus allow passage of ions through the normally inpermeant membrane [94]. The second
domain common to VGKCs is the transmembrane component that is able to sense changes in
voltage. Normally, this domain is identified by numerous positive charges, namely arginine
residues, which cause a conformation change upon sensing a change in the voltage of the system,
therefore opening or closing the pore [95]. Finally, the third domain reminiscent of VGKCs is
the intracellular regions that are responsible for various functions. Namely, binding to ligands
and structuring the channel through interactions that lead to the higher order oligomeric state of
the channel [96].
The overall architecture of the functional ion channels, specifically VGKCs, includes
helical domains that transverse the membrane and contribute to a central pore. Thus, these
channels are defined as integral membrane proteins. While some channels only have two
transmembrane segments (ex: inward rectifying potassium channels), other family members have
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either four (2-pore potassium channels), six (Kv1.2) or seven (Ca2+ activated potassium
channels) transmembrane domains per subunit. (Crystal structure and mechanism of a calciumgated potassium channel. [97] [98] [99] [100]. Despite this difference, all of these channels form
multimers as a functional protein. Interestingly, the VGKCs form symmetrical tetramers as the
functional channel, with each subunit contributing two transmembrane helices to the cylindrical
pore in what is termed as the “barrel stave” model (Figure 5B) [101]. The remaining
transmembrane helices, if present, help to stabilize this central pore. However, it is worth noting
other channels in various families appear as dimers (chloride channels), pentamers (nicotinic
acetylcholine receptor) and trimers (mechanosensitive channels). Despite these differences in
multimerization ion channels appear to possess some degree of oligomerization, which may be
relevant to APOL1 structure [102] [103] [104].
The ability of ion channels to have a preference for certain ions over others is due in part
to the selectivity filter. This highly conserved region is able to distinguish between cations and
anions, and even more incredibly the monovalent cations sodium and potassium. For instance,
the voltage gated potassium channels have a fidelity of nearly 10,000:1 for potassium over
sodium because of the pore loop, an intramembrane loop that exists between the pore forming
transmembrane domains and acts as the selectivity filter [93]. In the six transmembrane family of
VGKCs, this would be between helices five and six [105]. The highly conserved repeat of
TVGYG in the pore loop allows for the carboxyl backbone of the amino acids to coordinate with
the dehydrated potassium ion in an energetically favorable conformation [106]. Whereas the
smaller, but less energetically favorable, sodium ion is largely excluded from passing through the
channel. In the case of the voltage gated sodium channels and calcium channels, which have a
similar architecture to the VGKCs, they both have unique selectivity filters that help to exclude
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the incorrect ions. The voltage gated sodium channels, for instance, contain either an EEEE
(bacterial NaV) or DEKA (mammalian NaV) ring that selects for the smaller sodium ion in a
partially hydrated state and excludes the potassium ion [107]. Similarly, the calcium channels
utilize rings of negatively charged residues, but in this instance aspartate, as crucial ion binding
sites necessary for Ca2+ selectivity [108].

Kidney Disease and APOL1
Briefly, APOL1 has been associated with non-diabetic kidney disease in individuals with
recent African Ancestry. Specifically, individuals possessing two copies of the renal risk variants
G1 or G2 are at increased lifetime risk for developing focal segmental glomerulosclerosis,
hypertension-associated end stage kidney disease and HIV-associated nephropathy [77, 109,
110]. With an estimated 5 million African Americans at risk, the mechanism by which APOL1
leads to cytotoxicity is a strongly debated topic in the field [111]. Current mechanisms leading to
cell toxicity by the renal risk variants include altered localization to lipid droplets, stimulation of
the NLRP3 inflammasome, and opening of the mitochondrial permeation pore [81, 112, 113].
Unbelievably, all of these pathways have been proposed in just the past year. While we are not
directly addressing the role of APOL1 in kidney disease, we hope the work presented here can
contribute to future breakthroughs in understanding the mechanism behind cytotoxicity and drug
development.
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Research Questions:
Chapter 1
-

What is the effect of pH on APOL1 ion selectivity?

-

Identification of the pore lining region?

-

What residue(s) contribute to ion selectivity?

Chapter 2
-

Are the C-terminal leucine residues dispensable for APOL1 channel function?

-

Does disruption of the putative coiled-coil prevent channel formation?

-

Can APOL1 form oligomers in solution?

Chapter 3
-

What is the effect of proteases on the APOL1 Channel?

-

How many transmembrane domains exists in the APOL1 Channel?

-

What is the topology of the channel?
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Materials and Methods
PCR mutatgenesis
For bacterial expression of recombinant APOL1, the pNIC28 vector containing an Nterminal 6x His-tagged, G0 APOL1 (aa 28-398, accession no. O14791) was gifted by Russell
Thomson. All substitutions were performed by site-directed mutagenesis of the pNIC28 APOL1
(QuikChange II, Agilent Technologies). The protocol was precisely followed according to the
manufacturers specifications. But briefly, ~25 ng of plasmid DNA was mixed with 125 ng of
forward and reverse primers (see list below), dNTPs and reaction buffer. The PfuUltra DNA
polymerase (Agilent, 600850) allowed for new plasmid synthesis during 18 cycles in a Bio-Rad,
C1000 Touch Thermal Cycler. Template DNA was then digested with Dpn1 (Agilent, 500402)
prior to transformation into Stellar Competent cells (Takara, 636763).
Primer List
APOL1 G58C
5’ – GGGTCCATGGTGCAAGCAGCCCAGTC
3’ – GACTGGGCTGCTTGCACCATGGACCC
APOL1 I68C
5’ – GAAATACTTAATGGCATCCTCGCAAAAGATACTGCTCTCTGGGTCCATG – 3’
3’ – CATGGACCCAGAGAGCAGTATCTTTTGCGAGGATGCCATTAAGTATTTC – 5’
APOL1 K78C
5’ – GCAGATTCTGTGTGCTCACGCATTCCTTGAAATACTTAATGGC
ATCCTCAATAAAG – 3’
3’ – CTTTATTGAGGATGCCATTAAGTATTTCAAGGAATGCGTGAGCAC
ACAGAATCTGC – 5’
APOL1 L88C
5’ – GTTCCAGGCCTCATTATCAGTGCACAGGAGTAGCAGATTCTGTGT – 3’
3’ – ACACAGAATCTGCTACTCCTGTGCACTGATAATGAGGCCTGGAAC – 5’
APOL1 V98C
5’ – GCAGTTCAGCAGCAGCGCAGAATCCGTTCCAGGCC – 3’
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3’ – GGCCTGGAACGGATTCTGCGCTGCTGCTGAACTGC – 5’
APOL1 A108C
5’ – GAGCTTTACGGAGCTCATCGCACTCATTCCTGGGCACTTCA – 3’
3’ – TGAAGTGCCCAGGAATGAGTGCGATGAGCTCCGTAAAGCTC – 5’
APOL1 L118C
5’ – TTCATGATCATTTGTCTTGCACAGTTGTCCAGAGCTTTACGGAG – 3’
3’ – CTCCGTAAAGCTCTGGACAACTGTGCAAGACAAATGATCATGAA – 5’
APOL1 N128C
5’ – GCCTTTATCGTGCCAGCATTTGTCTTTCATGATCATTTGTCTTGCA – 3’
3’ – TGCAAGACAAATGATCATGAAAGACAAATGCTGGCACGATAAAGGC – 5’
APOL1 F140C
5’ – CAGCAGTACAGAAACTGGTGTCTGAAAGAGTTTCCTCGGTTGAAAAG – 3’
3’ – CTTTTCAACCGAGGAAACTCTTTCAGACACCAGTTTCTGTACTGCTG – 5’
APOL1 K148C
5’ – CTTCTTATGTTATCCTCAAGCTTACTGCACAACCGA
GGAAACTCTTTCAGAAACC – 3’
3’ – GAAGAATACAATAGGAGTTCGAATGACGTGTTGGCTCC
TTTGAGAAAGTCTTTGG – 5’
APOL1 L158C
5’ – CCATCTGCAAGGGCACGGCACCTTCTTATGTTATCCTCA – 3’
3’ – GGTAGACGTTCCCGTGCCGTGGAAGAATACAATAGGAGT – 5’
APOL1 V168C
5’ – TGGTGGTGCCTTTGTGGCACTTCTGAACCCCATCTG – 3’
3’ – ACCACCACGGAAACACCGTGAAGACTTGGGGTAGAC – 5’
APOL1 V178C
5’ – AAATGCTGAGAGAGCCAGAGCACACATTGGCGATGGTGGTG – 3’
3’ – TTTACGACTCTCTCGGTCTCGTGTGTAACCGCTACCACCAC – 5’
APOL1 I188C
5’ – CCGACGAGGGTCAGGCAGCCAGAGGAAATGCT – 3’
3’ – GGCTGCTCCCAGTCCGTCGGTCTCCTTTACGA – 5’
APOL1 F199C
5’ – GGTCTGGCACCCTGCACAGAGGGAGGCAGCCTTGTACTCTTG – 3’
3’ – CAAGAGTACAAGGCTGCCTCCCTCTGTGCAGGGTGCCAGACC – 5’
APOL1 E201C
5’ – AAGGCTGCCTCCACATGTGAAGGGTGCCAGACCCATGC – 3’

27

3’ – TTCCGACGGAGGTGTACACTTCCCACGGTCTGGGTACG – 5’
APOL1 L208C
5’ – CAACTCCATCCCAGGTTCGCAGAGTACAAGGCTGCCTC – 3’
3’ – GTTGAGGTAGGGTCCAAGCGTCTCATGTTCCGACGGAG – 5’
APOL1 T217C
5’ – GGGATGGAGTTGGGAATCTGCGCAGCTTTGACCGGGATT – 3’
3’ – CCCTACCTCAACCCTTAGACGCGTCGAAACTGGCCCTAA – 5’
APOL1 A228C
5’ – CACCACTTCTTTCCGTAGTCGCAGGTACTGCTGGTAATCCCGG – 3’
3’ – GTGGTGAAGAAAGGCATCAGCGTCCATGACGACCATTAGGGCC – 5’
APOL1 A238C
5’ – GGTCGTGGGCTTGGCATTGTGTCCACCACTTCT – 3’
3’ – CCAGCACCCGAACCGTAACACAGGTGGTGAAGA – 5’
APOL1 V244C
5’ – TTGTCAAGGCTTTTGATGCACAGGTCGTGGGCTTGGG – 3’
3’ – AACAGTTCCGAAAACTACGTGTCCAGCACCCGAACCC – 5’
APOL1 L248C
5’ – CACCTCCTTCAATTTGTCACAGCTTTTGATGACCAGGTCG – 3’
3’ – GTGGAGGAAGTTAAACAGTGTCGAAAACTACTGGTCCAGC – 5’
APOL1 L258C
5’ – GTTGGATATGTTCTCACCGCAAAACTCCTTCACCTCCTTCAATT – 3’
3’ – CAACCTATACAAGAGTGGCGTTTTGAGGAAGTGGAGGAAGTTAA – 5’
APOL1 L268C
5’ – GGTGAGAACATATCCAACTTTCTTTCCTGTGCTGGCAATACTTAC – 3’
3’ – CCACTCTTGTATAGGTTGAAAGAAAGGACACGACCGTTATGAATG – 5’
APOL1 G278C
5’ – TGTCCTTCCCAATGCATCGTGTGAGTTGGTAAGTA – 3’
3’ – ACAGGAAGGGTTACGTAGCACACTCAACCATTCAT – 5’
APOL1 R288C
5’ – CCTTCCCAATGCCACATTGAGTTGGTAAGTATTGCCAGCT – 3’
3’ – GGAAGGGTTACGGTGTAACTCAACCATTCATAACGGTCGA – 5’
APOL1 H298C
5’ – GCGTGAGGCTGAGGCACACGGTACTGACTGAAGA – 3’
3’ – CGCACTCCGACTCCGTGTGCCATGACTGACTTCT – 5’
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APOL1 R305C
5’ – TTGGCTCAGTGACGCAGGGGGCGTGAGGCT – 3’
3’ – AACCGAGTCACTGCGTCCCCCGCACTCCGA – 5’
APOL1 E328C
5’ – GAGCTTGACTCCTCTGCTCATGGACAGGATGCTGGGTTCATTAAC – 3’
3’ – CTCGAACTGAGGAGACGAGTACCTGTCCTACGACCCAAGTAATTG – 5’
APOL1 V338C
5’ – GAAGCTTACAGGGGCGCAATCCGTGAGCTTGACTCCTCTG – 3’
3’ – CTTCGAATGTCCCCGCGTTAGGCACTCGAACTGAGGAGAC – 5’
APOL1 V346C
5’ – GTAGACTACATCCAGACAAAGAAAGAACCTTACAGGGGCCACATCC – 3’
3’ – CATCTGATGTAGGTCTGTTTCTTTCTTGGAATGTCCCCGGTGTAGG – 5’
APOL1 D348C
5’ – CGTACACGAGGTAGACTACACACAGCACAAGAAAGAAGCTTA – 3’
3’ – GCATGTGCTCCATCTGATGTGTGTCGTGTTCTTTCTTCGAAT – 5’
APOL1 A363C
5’ – TCCTAGCTGTCTCTGACTTGCACCCCTCATGTAAGTGCTTTG – 3’
3’ – AGGATCGACAGAGACTGAACGTGGGGAGTACATTCACGAAAC – 5’
APOL1 K373C
5’ – TCCAGCTCCTGAGCCACACACTTCAGCTCCTCAGCTG – 3’
3’ – AGGTCGAGGACTCGGTGTGTGAAGTCGAGGAGTCGAC – 5’
APOL1 A375C
5’ – CTCCTCCAGCTCCTGACACACCTTCTTCAGCTCC – 3’
3’ – GAGGAGGTCGAGGACTGTGTGGAAGAAGTCGAGG – 5’
APOL1 N387C
5’ – CCGCCTGCAGAATCTTATAATTACAGTTGAGAATGTTTAGCTTCTCCT – 3’
3’ – GGCGGACGTCTTAGAATATTAATGTCAACTCTTACAAATCGAAGAGGA – 5’
APOL1 D337N
5’ – TTACAGGGGCCACATTCGTGAGCTTGACTCC – 3’
3’ – AATGTCCCCGGTGTAAGCACTCGAACTGAGG – 5’
APOL1 D348N
5’ – GCTTCTTTCTTGTGCTGAATGTAGTCTACCTCGTG – 3’
3’ – CGAAGAAAGAACACGACTTACATCAGATGGAGCAC – 5’
APOL1 D348H
5’ – CACGAGGTAGACTACATGCAGCACAAGAAAGAAGC – 3’
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3’ – GTGCTCCATCTGATGTACGTCGTGTTCTTTCTTCG – 5’
APOL1 LZA 1 (First)
5’ – CTGAGCCACCTTCTTCGCCTCCTCAGCTGTCTCT – 3’
3’ – AGAGACAGCTGAGGAGGCGAAGAAGGTGGCTCAG – 5’
APOL1 LZA 2 (On LZA 1 plasmid)
5’ – GTTTAGCTTCTCCTCCGCCTCCTGAGCCACCTTC – 3’
3’ – GAAGGTGGCTCAGGAGGCGGAGGAGAAGCTAAAC – 5’
APOL1 LZA 3 (On LZA 2 plasmid)
5’ – GCAGGCGGAGGAGAAAGCTAAACATTGCCAACAATAATTATAAGATTCTGC – 3’
3’ – GCAGAATCTTATAATTATTGTTGGCAATGTTTAGCTTTCTCCTCCGCCTGC – 5’
APOL1 LZA 4
5’ – TTCTTGGTCCGCCTGCGCAATCTTATAATTATTGTTGAGAATGTTTAGC – 3’
3’ – GCTAAACATTCTCAACAATAATTATAAGATTGCGCAGGCGGACCAAGAA – 5’
APOL1 LZA 5 (On LZA 4 plasmid)
5’ – CGCAATCTTATAATTATTGCCGGCAATGTTTAGCTTCTCCTCCAGCTCC – 3’
3’ – GGAGCTGGAGGAGAAGCTAAACATTGCCGGCAATAATTATAAGATTGCG – 5’
APOL1 LZA 6 (On LZA 5 plasmid)
5’ – GTTTAGCTTCTCCTCCGCCTCCTGAGCCACCTTC – 3’
3’ – GAAGGTGGCTCAGGAGGCGGAGGAGAAGCTAAAC – 5’
APOL1 protein purification
(For a detailed methodology see appendix 1)
The pNIC28 plasmid containing the His-tagged APOL1 gene is transformed into Bl21DE3-RIPL cells, and grown for 16-18 hours in Overnight Express Media. The bacteria are then
pelleted, and the inclusion bodes isolated. After solubilizing the inclusion bodes in the presence
of Zwittergent 3-14, the APOL1 protein is subject to His-Affinity Purification and Size
Exclusion Chromatography. The fractions are then run on an SDS-PAGE gel and coomassie
stained to confirm correct predicted band size and minimal contamination.
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Purification of MPB Labeled Proteins
Approximately 500 uL of rAPOL1 protein (11.6 uM) is incubated with 1 mM MPB for
one hour at room temperature. After incubation, proteins are added to a 2 mL Centrifuge Column
(Pierce, 89896) packed with 1 mL of monomeric avidin bond to sepharose beads (Pierce, 20228).
The flow through is discarded, and the bound MPB labeled APOL1 protein is eluted with buffer
containing 1 mM biotin. The excess biotin is removed by repeated rounds of washing in a Ultra15 Centrifugal Filter Unit with a 10,000 Dalton molecular weight cut-off (Amicon, UFC901024).
The resulting protein solution is then concentrated down to ~500 uL, aliquoted and flash frozen
in liquid nitrogen for storage at -80*C.
24-hour trypanolytic killing assay
Lister-427 derived T. b brucei 427 were grown and cultured in HMI-9 medium. The
human serum sensitive cell line was then exposed to rAPOL1 dilutions of the various mutants
purified (indicated for each graph). The assay was performed in a 96-well plate, in which 5 x
10^5 cells/mL were combined with the rAPOL1 (done in triplicate) and allowed to incubate for
20 hours at 37*C (5% C02). The viability of each well was assessed using the alamarBlue assay
as described by the manufacturer (Invitrogen, DAL1100). Data was analyzed and graphed using
Prism 7 software by GraphPad.
Planar lipid bilayer experiments
Both the polar lipids from asolectin (lecithin type IIS from Sigma) and cholesterol
(sigma, C8667) were dissolved together in pentane at concentrations of 1.5% and 0.5% (wt/vol),
respectively. At room temperature, a Teflon partition with a ~100 um hole, separating two
chambers of 1 mL total volume each, was coated with 3% (vol/vol) squalene (Sigma, S3626) in
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petroleum ether. The solvent was then allowed to evaporate, and buffer was added to both the cis
and trans chambers via syringes. The solutions were next layered with 20 uL of the
asolectin/cholesterol solution, and the trans chamber solution was raised above the hole,
immediately followed by the cis chamber. At this time, we expected a change in the capacitance
roughly equivalent to 100 pF. If not observed, the solutions levels were brought below the hole,
and then raised again. This process was repeated until a stable bilayer was formed as evidenced
by the measured capacitance.
Salt bridges made of 3% (wt/vol) agar and 3 M KCl connected the Ag/AgCl electrodes to
the solutions in the cis and trans compartments. The starting buffer solution contained 5 mM
Potassium Succinate, 5 mM HEPES, 150 mM KCl, 5 mM CaCl2 and 0.5 mM EDTA, pH 7.2
unless otherwise stated. Each chamber had a lower depression to allow for stirring by magnetic
fleas so the pH could be titrated by addition of HCl or KOH. Voltage of the system was
maintained by the BC-535C bilayer clamp (Warner Instruments), and the current output was
passed through a low-pass eight pole Bessel filter (Warner Instruments) at 10 Hz. For this setup,
voltage is applied relative to the cis chamber. Recording of the current response was done with
IGOR NIDAQ Tools MX 1.0 and IGOR software (WaveMetrics) using the National Instruments
analog to digital converter (NI USB-6211).
The selectivity of various APOL1 channels was done by measuring the reversal potential
of macroscopic conductance with varying cis:trans activity gradients. Addition of 50 uL of 3 M
KCl to the cis solution created an ion gradient, and the voltage required to zero the current
(reversal potential) was acquired. The measurement of the reversal potential at numerous ion
concentration gradients was compared to ideal cation and anion selectivity’s as determined by
the Nernst Potential:
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Erev = -59 mV x log10 [αK+cis/ αK+trans]
Where αK+ is the relative activity of the potassium ion due to ionic interactions in the buffer
solution, which is based on the Debye-Huckel limiting law.
Dimerization assays
Recombinant APOL1 proteins were diluted into buffer containing 5 mM Succinate, 5
mM HEPES, 150 mM KCl, 5 mM CaCl2 and 0.5 mM EDTA, pH 7.2 (same as bilayer
experiments). The buffer obviously lacked reducing agents such as DTT or B-mercaptoethanol
because we wanted to promote the formation of disulfide bonds. We could use 1 M HCl or KOH
to titrate the solutions between pH 5.6 and pH 7.2, respectively. Approximately 232 nM
concentrations of the APOL1 proteins were incubated at room temperature for a total of two
hours. The varying conditions included: two hours at pH 7.2, one hour at pH 5.6 and one hour at
pH 7.2, and two hours at pH 5.6 followed by a brief neutralization. 30 uL of sample were then
added to 35 uL 2x Laemmli Sample Buffer (Bio-Rad, 1610737), and a total of 25 uL of sample
(~25 ng protein) was run on an AnyKD Tris-Glycine gel (Bio-Rad, 4569033) at 110 V for ~1.5
hours. The gels were then silver stained in accordance with the manufacturer’s instructions
(Pierce, 24612). In experiments testing the effects of SRA on disulfide formation, a two-fold
molar excess of SRA was present under all conditions (~450 nM).
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Chapter 1: Identifying the Selectivity filter and Pore Lining
Region of APOL1
Introduction:
Humans have an innate immunity to some Trypanosoma species (sp.) because of a subset
of high-density lipoproteins termed Trypanosome Lytic Factors[43]. Two integral components of
this complex, Apoliporotein A-1 and Haptoglobin-related protein, form the structural scaffold
and the ligand for receptor-mediated endocytosis, respectively [46, 47]. The lytic component of
this complex, Apolipoprotein L1, is a pH-gated ion channel and the focus of this study [16].
Uptake of TLF, and thus APOL1, into the parasite is necessary for Trypanolysis, and is
facilitated by clathrin mediated endocystosis [114]. These clathrin-coated vesicles are then
trafficked to the endosome, which is acidified by V-ATPases, with the help from Adapter
Protein-2 complexes. [115, 116]. Now activated, the APOL1 causes colloid osmotic swelling and
lysis due to equilibration of the ion electrochemical potential by cation flux across the plasma
membrane [41], which could be explained by trafficking of APOL1 to the plasma membrane
resulting in channels selective for cations at the cell surface. Indeed, recombinant APOL1 is able
to lyse trypanosomes in vitro, as well as form pH-gated ion channels in planar lipid bilayers [16].
Within this system, APOL1 will only insert into phospholipid/cholesterol membranes at acidic
pH, and opens upon subsequent neutralization, thus mimicking the conditions during vesicular
recycling from the acidic endosome to the plasma membrane with subsequent exposure to the
neutral environment of the extracellular milieu.
Currently, the exact mechanism for ion channel formation by APOL1 is poorly
understood. Secondary structure prediction software identifies three putative transmembrane
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domains [14]. Most notably, the first two predicted transmembrane domains form a Helix-LoopHelix (HLH) structure (residues 60-235), reminiscent of bacterial colicins and diphtheria toxins.
A peptide fragment containing only the HLH helices (TM 8 and 9) of Dptx is able to insert into
planar lipid bilayers at acidic pH and form pores with similar conductance to that of full-length
diphtheria toxin [79]. A similar peptide of APOL1 (HLH helicies TM 1 and 2) was generated
and tested in planar lipid bilayers (residues 60-235), however the properties of the observed
conductance are vastly different than that of full-length rAPOL1 [15]. Despite this finding, the
region (residues 60-235) has been extensively referred to as the pore forming domain of APOL1,
although there is little evidence to support this claim other than the structural similarity.
The C-terminal domain of APOL1 has been scarcely studied as a region involved in
channel formation, although this is the site of interaction with Serum Resistance Associated
Protein (SRA). Specific to the human infective parasite T. brucei rhodesiense, SRA binds to the
C-terminus of APOL1 under acidic conditions and prevents trypanolysis both in vivo and in vitro
[14, 61]. In planar lipid bilayers, pre-addition of SRA to the cis chamber prevents channel
formation upon neutralization [16]. However, a stable acidic conductance was formed,
suggesting APOL1 was still able to insert into the membrane but was unable to open at neutral
pH. Furthermore, the same group noted deleting more than 10 of the final C-terminal amino
acids resulted in loss of trypanolytic activity and channel forming properties. Despite all this, the
precise involvement of the C-terminus in channel formation of APOL1 is still unknown.
While the domains of APOL1 are yet to be confirmed, it is generally understood that the
protein forms cation-selective channels in the open conformation. In planar lipid bilayers, after
rAPOL1 channels were formed, a five-fold trans:cis ion activity gradient was generated, and
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further manipulated by adding 3 M KCl to the cis chamber (Figure 6A). Under conditions of
cis/trans pH 7.2, rAPOL1 was found to be ideally selective for both potassium and sodium over
chloride ions [16]. Additionally, a second group inserted rAPOL1 into unilamellar lipid vesicles,
and measured chloride efflux from the liposomes when paired with various ionophores(Figure
6B). When rAPOL1 was first inserted into the lipid vesicles at acidic pH and subsequently paired
with the chloride ionophore CI1 at neutral pH 8.0, there was chloride efflux from the liposomes,
indicating rAPOL1 was able to generate a cation-selective counter-current [65]. However, the
group noted chloride efflux at extracellular pH 5.0 when rAPOL1 was paired with the potassium
ionophore valinomycin, signifying APOL1 was permeable to chloride ions. Although the
authors noticed the similarity to bacterial colicins, which also confer pH- switchable ion
selectivity, they did perform amino acid substitutions to identify the residue(s) involved [117]. In
contrast to this result, the selectivity of APOL1 from purified TLF was tested in the low
conductance (acidic pH) state in planar lipid bilayers, and the protein was found to be primarily
permissive to cations [55]. With the conflicting results in the low conductance state, it is unclear
as to the exact effect of pH on selectivity and what residue(s) are involved.

Results:
Utilizing the secondary structure prediction software Jpred 4, we identified four putative
transmembrane domains (TM) within APOL1. The first two form a putative HLH, similar to
bacterial colicins and diphtheria toxin, whereas the latter two transmembranes (TM 3 and TM 4)
are independent of one another (Figure 7). We hypothesized at least one of the predicted
transmembranes could be the pore lining region or the selectivity filter of APOL1. But without
further information, it would be difficult to identify the residue(s) responsible.
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To better characterize the selectivity of APOL1, we wanted to test the effect of pH on the
channel’s preference for cations. We first tested the selectivity in planar lipid bilayers at pH 7.2
cis/pH 7.2 trans, and confirmed the previously published result that APOL1 is an ideally
selective cation channel. However, APOL1 appeared to lose cation selectivity as the cis chamber
was changed to pH 5.6, and was further reduced when dropped to pH 5.4 (Figure 8). This
property is reminiscent of bacterial colicins, which loses their cation selectivity as the cis pH is
dropped [118]. However, unlike the bacterial colicin, APOL1 has three glutamate residues in its
HLH, and maintained its ideal cation selectivity under the reverse conditions of cis pH 7.2/trans
pH 5.6 (Figure 8). Considering this result, we wanted to test if the amino acids in the putative
HLH, specifically the three glutamate (E) residues reminiscent of diphtheria toxin, had an effect
on channel selectivity.

Because of unpublished work by Russell Thomson, we know the baboon variant of
APOL1 is not ideally cation selective at pH 7.2 cis/pH 7.2 trans (data not shown). Because the
baboon shares only one of the glutamate residues in the HLH with human APOL1, we reasoned
that one or both of the other two could contribute to APOL1 pH-regulated cation selectivity.
However, amino acid changes of glutamate-201 to alanine (E201A) and/or glutamate-213 to
glycine (E213G) in the human APOL1 to mimic the baboon residues, resulted in a protein that
remained ideally cation selective at cis pH 7.2 (Figure 9). Furthermore, the substitutions had no
effect on APOL1 lytic activity in an in vitro Trypanolytic killing assay (data not shown).
Therefore, it is unlikely the glutamates in the HLH region are responsible for APOL1 ion
selectivity.
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Seeing as Thomson and Finkelstein documented the importance of the C-terminus in
APOL1 function, we focused on the final predicted transmembrane sequence of APOL1 to try
and elucidate the channel selectivity filter. This region spans amino acids 335-356, and
noticeably includes two aspartate residues at positions 337 and 348, and one glutamate residue at
position 355 (Figure 7). Hypothesizing either of these residues could contribute to channel cation
selectivity because they become de-protonated at neutral pH, we individually substituted an
asparagine in place of the aspartate. Accordingly, overall R-group structure was maintained,
although the side chain is now polar-uncharged. The APOL1 proteins, aspartate-337 to
asparagine (D337N) and aspartate-348 to asparagine, were then subjected to in vitro trypanolytic
assays to test lytic capacity (Figure 9). APOL1 D337N retained lytic activity with an LD50 ≈ 100
ng/mL, nearly identical to that of the G0 APOL1 (Figure 9). In addition, the there was no effect
of the D337N substitution on channel formation or pH gating in the planar lipid bilayer system
(Figure 12). Conversely, D348N was unable to lyse T. b. brucei 427 at concentrations nearly
eight-fold higher than the LD50 of approximately ~100 ng/mL for G0 APOL1 (Figure 10). This
was consistent with a severely diminished acid-to-neutral macroscopic conductance increase of
D348N, only 2-3 fold, when compared directly to G0 APOL1 (200-500 fold) during the same
planar lipid bilayer experiment (Figure 13).
We then investigated the effect of the D337 and D348 substitutions on ion selectivity of
the human APOL1 channel. Whereas APOL1 D337N remained ideally cation-selective at pH 7.2
cis/pH 7.2 trans, the D348N substitution resulted in a shift towards anion selectivity (Figure 11).
If cation selectivity was due to the de-protonation of aspartate at neutral pH, then the selectivity
of APOL1 at acidic pH should be comparable to that of D348N APOL1 at neutral pH. Indeed,
we found G0 APOL1 to have non-ideal cation selectivity at pH 5.4 comparable to the APOL1
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D348N at neutral pH (Figure 8), suggesting that titration of D348 is responsible for pHdependent selectivity of G0 APOL1.
To confirm the contribution of this residue to selectivity, we replaced aspartate-348 with
a histidine (H), an amino acid side chain that becomes positively charged below pH 6.1. Like
APOL1 D348N, the D348H substitution resulted in a protein unable to lyse African
trypanosomes in vitro (Figure 10). Additionally, the D348H substitution resulted in a channel
that minimally responds to pH, with only a ~2 fold increase in macroscopic conductance upon
neutralization, reminiscent of the effect seen with the D348N substitution (Figure 14A).
Remarkably however, the histidine substitution resulted in almost complete loss of ion selectivity
in planar lipid bilayers at neutral pH, whereas at acidic pH 6.1, the macroscopic conductance
became strongly anion-selective (Figure 14B). This result suggests that protonation of the
substituted histidine at pH 6.1 governs the shift toward anion selectivity. Taken together, these
data strongly suggest that protonation of the aspartic acid at position 348 governs APOL1
selectivity.
Discussion:
While it is well understood that APOL1 is a pH-gated cation channel, the domains
responsible have yet to be categorized. More specifically, the pore-lining region and selectivity
filter have yet to be identified. With previous established work showing that recombinant
APOL1 can form conductances in planar lipid bilayers, we began to test the effects of amino acid
substitutions in this system. Although the putative HLH has been heavily implicated throughout
the literature, we found that amino acid substitutions within this region had no effect on APOL1
ion selectivity. With a paper by Thomson and Finkelstein highlighting the importance of the Cterminus for channel functions, we began assessing negatively charged residues in this domain.

44

45

Interestingly, the substitution of D348N resulted in diminished macroscopic channel
conductance and a loss of cation selectivity, indicating that the pore- lining region is constituted,
at least in part, by the fourth predicted transmembrane domain (residues 335-356). Furthermore,
replacing the aspartic acid at this position with a histidine resulted in an APOL1 channel that was
anion selective at acidic pH. Taken together, these data challenge and significantly add to the
current understanding of APOL1 structure and domains.
Based on previous findings and potential similarities to diphtheria toxin and bacterial
colicins, our lab extensively explored the predicted HLH of APOL1 as the potential pore-lining
region. However, we found no evidence that the HLH itself lines the ion channel, as the
E201A/E213G substitutions had no effect on channel selectivity (Figure 9). This is in contrast to
the pore-forming DpTx, wherein substitution of charged HLH residues affected either single
channel conductance, or both selectivity and conductance [84, 85]. Moreover, a minimal peptide
fragment containing just the HLH of diphtheria toxin or colicin was sufficient to form channels
in planar lipid bilayers with similar properties to the full-length peptide [79, 89]. While a similar
fragment of APOL1 (residues 60-235) was shown to form chloride selective channels, it lacked
the ideal cation selectivity we have described here, and is therefore difficult to compare to our
findings [15].
Also in contrast to the bacterial pore-forming toxins, APOL1 contains some 170 amino
acids C-terminal of the HLH. Truncation at the C-terminus of 10 or more amino acids abolished
trypanolytic activity and is associated with loss of channel-forming ability [16, 71, 119].
Focusing on the C-terminal putative transmembrane domain as a prospective channel-lining
region (residues 335-356), we identified two charged aspartates (residues 337 and 348) and a
glutamate-355 (Russell Thomson, unpublished) that may influence selectivity and pH gating.
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Substitution of aspartate to asparagine (D337N) within the putative transmembrane region had
no effect on either the pH-dependent conductance properties or charge selectivity (Figure 11 and
12). The D337N substitution happens to be a naturally occurring variant within the human
population, and we did not find any functional differences concerning channel properties [120].
Conversely, the glutamate-355 was found to play a small role in pH gating of human APOL1
(Russell Thomson, unpublished). Substitution with glutamine residue resulted ~1 pH unit shift in
channel opening towards a more basic environment, while substitution with glycine had the
opposite effect (~1 pH unit towards acidic). Based on this evidence it stands to reason that
glutamate-355 may be a pH sensor, or more likely affects the microenvironment of the actual pH
sensor.
Whereas the glutamate-355 had a small effect on channel gating, aspartate-348 appears to
be crucially important to the pH-dependent conductance of cations through the channel. The
D348N substitution in particular was associated with reduced overall ion conductance compared
to G0 APOL1, and decreased cation selectivity at neutral pH similar to G0 APOL1 at pH 5.4
(Figure 11 and 13). Substitution for histidine (D348H) reduced cation selectivity still further at
neutral pH, and actually reversed selectivity to anions at acidic pH 6.1 (Figure 14). We were
unable to drop the pH further, as thechannels became largely unstable at pH < 6.0. But with
histidine having an R-group pKa = 6.0, it stands to reason that a further decrease may have led to
an ideally anion selective channel. Interestingly, there is a similar effect observed with the
TASK-1 family of two-pore potassium channels, in which mutations that caused loss of
selectivity also reduced channel conductance upon pH gating [121]. Notwithstanding, we find no
evidence at this time that APOL1 has any structural or domain similarities to this family of
channel proteins. Additionally, a double mutant of D348N/E355Q rAPOL1 tested by Russell
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Thomson had no channel gating response upon neutralization, heavily implicating these two
residues as the main pH sensors (Fig 10). But regarding charge selectivity (cations versus anions)
of APOL1, it appears to be electrostatic in nature, and is dependent to a large extent on the
protonation status of a single residue, aspartate-348.
Having now identified the selectivity filter, we will try to set the record straight regarding
APOL1 selectivity. Our findings agree with previously published reports that APOL1 is cation
selective at neutral pH in both planar lipid bilayers and lipid vesicles [16, 65]. However, there is
conflicting data on the selectivity of APOL1 at acidic pH. Utilizing TLF purified from humans,
Portela et al. found APOL1 to be non-ideally cation selective in planar lipid bilayers, with a
pK/pCl of ~4.65 at cis pH 5.5/trans pH 7.4 [55]. Compared to our results, this falls between our
estimates of pK/pCl ~5.1 at cis pH 5.6 and ~2.88 at cis pH 5.4, in agreement with our assessment
that APOL1 becomes increasingly anion selective as the aspartate-348 is protonated/neutralized.
But when full-length recombinant APOL1 was inserted into phospholipid liposomes at pH 5.0,
anion conductance was observed when paired with the cation carrier valinomycin, suggesting
APOL1 was selecting chloride over potassium in the system [65]. However, the anion selective
conductance at pH 5.0 was rather large compared to what we find here, and it is feasible this is
the result of a different species altogether. Additionally, they did observe a small potassium
efflux when paired with the chloride carrier Cl1 at extracellular pH 5.0, indicating APOL1 most
likely allows the efflux of both potassium and chloride in the inserted/closed state, as we have
found here. This further supports the idea that protonation/de-protonation of aspartate-348
controls ion selectivity of APOL1.
The findings in this section also shed light on the mechanism of trypanolysis by APOL1.
It has long been understood that cation flux across the plasma membrane is followed by
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cytoplasmic swelling when trypanosomes are treated with human serum [41]. This effect can be
delayed by adding sucrose to the growth media to prevent osmotic swelling, or if NaCl is
partially replaced with the larger ions tetramethylammonium+ (for Na+) or gluconate- (for Cl-),
thus preventing ion flow across the membrane [55], therein supporting the hypothesis that
APOL1 forms cell surface channels after insertion into the endosome membrane. Other groups
have suggested APOL1 forms pores in the lysosomal membrane, causing lysosomal swelling and
eventual parasite death [13, 15, 54]. A recent paper observed that lysis results from both
lysosomal and mitochondrial membrane disruption, the latter of which is due to the formation of
APOL1 megapores in the outer mitochondrial membrane [60]. In regards to the lysosome
hypothesis, the residues responsible for pH gating would never “see” pH 7.2 after acidification in
the lysosome, so the channels would presumably remain in the closed state with minimal
conductance. Considering the loss-of function D348N and D348H substitutions result in
decreased open state conductance at neutral pH, but appear to have no effect on insertion or the
closed channel conductance at acidic pH (Figure 13 and 14), it appears that trypanolysis is
dependent on the open state of the APOL1 channel. The formation of APOL1 megapores in the
mitochondrial membrane also seems unlikely, as we have never observed anything other than the
highly ion-selective, pH-gated properties of APOL1 described herein. Although APOL1 could
possibly collaborate with other trypanosome proteins to form a megapore, it would remain to be
explained how the loss of function D348N and D348H substitutions might affect this process
(Figure 10). Rather, we show the APOL1 D348N and D348H substitutions dramatically reduce
APOL1 cation channel conductance while eliminating trypanosome killing. Therefore, the data
further backs the notion that endocytic recycling of APOL1 drives colloid osmotic lysis of the
trypanosome via the pH dependent opening of APOL1 cation channels in the plasma membrane.
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With a firm understanding of the selectivity of the APOL1 channel, we wanted to
speculate on the pore size. Both unpublished by Russell Thomson and published data indicate
APOL1 is a non-selective cation channel, meaning it allows the passage of multiple cations (Na+,
K+, Ca2+) [16]. The selectivity experiments presented here are performed exclusively with
potassium, the largest of the three ions permissible to APOL1, which has a crystal radius of ~3 Â
[122]. The family of voltage-gated potassium channels (VGKC) have a pore diameter of ~5 Â,
which permit the diffusion of dehydrated potassium ions through the channel [100, 123].
However, potassium channels are highly selective for potassium over other cations, whereas
APOL1 permits the flux of both Na+ and Ca2+ in addition to potassium. Therefore the pore
diameter of APOL1 is likely different than that of the VGKCs. Still, it can be expected the
APOL1 pore cannot be smaller than that of the VGKC channel considering it generates a
potassium dependent conductance in planar lipid bilayers [16]. To determine an upper estimate
of pore diameter, we turned to the colicin family of bacterial toxins, of which APOL1 shares a
putative helix-loop-helix motif. Colicin A and B both permit diffusion of sodium and potassium
[124]. However, they also permit the larger monovalent ions rubidium, cesium and
tetraethylammonium to pass through the pore. It is interesting to note that replacing sodium in
the media with tetraethylammonium delays APOL1 mediated trypanolysis, thus we can infer the
molecule is unable to pass through the APOL1 channel [55]. Considering colicin E1, which is
predicted to be similar to colicin B, was experimentally determined to have a minimum pore
diameter of ~8 angstroms, which we would expect to be the upper limit for the APOL1 pore
diameter [117]. Furthermore, the class of non-selective cation channels (NSCCs), specifically the
nicotinic acetylcholine receptor, could also be a suitable gauge of APOL1 pore diameter. The
functional channel allows permeation of Na+, K+ and Ca2+, and utilizes two rings of negatively
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charged amino acids to confer cation selectivity by repulsion of anions [125]. These channels
have an estimated pore radius of ~6.5 Â, and due to the similarities in selectivity and amino acid
composition be fairly analogous to APOL1 channels [93]. Taken together, we predict the
minimum pore radius of the APOL1 channel to be ~6.5 Â, with a lower limit of 5 Â and an upper
limit of 8 Â.
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Chapter 2: Assessment of the C-terminal Heptad Repeat Motif in
Channel Oligomerization
Introduction:
The APOL1 protein gives humans resistance to the animal infective parasite T. brucei
brucei due to its ability to form ion channels in the parasite plasma membrane [16]. However,
humans are still infected by the subspecies T. brucei rhodesiense due to the expression of a
single protein, serum resistance-associated protein (SRA) [13, 70]. Surface plasmon resonance
experiments of C-terminal peptide fragments (residues 365-398) show SRA binds to this region
with nano-molar affinity under acidic conditions, which is likely mediated by an electrostatic
interaction rather than hydrophobic [13, 14, 73]. When pre-added to planar lipid bilayer
experiments, recombinant SRA did not appear to have an effect on APOL1 insertion at acidic
pH. However, it does prevent APOL1 channel formation upon neutralization, thus hinting at the
importance of the C-terminus for channel formation [16]. Additionally, the same group reported
truncations of APOL1 (del: 349-398) prevented APOL1 membrane insertion and channel
opening.
Secondary structure prediction software Jpred 4 identifies a putative heptad repeat in the
C-terminus of APOL1 (Figure 18). The protein-folding motif often forms a superhelical structure
consisting of two or more alpha helices, and is stabilized by both van der waals and electrostatic
forces (Figure 17) [126]. Based on the occurrence of this structural motif, it is reasonable to
assume the APOL1 channel is an oligomer. In support of this theory, replacement of amino acids
residing in the hydrophobic core resulted in either partial (alanine) or complete (serine) loss of
Trypanolytic activity in vitro [71]. Furthermore, a recent computational approach determined
APOL1 to be a homopentamer, although this has not been confirmed experimentally [81].
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APOL1 oligomerization has also been implicated in kidney disease of those with recent African
Ancestry [77]. The renal risk variants, G1 (S342G/I384M) and G2 (del: 388/389), were found to
form numerous higher order oligomers in the mitochondria, unlike the ancestral G0 we have
focused on here [113]. Interestingly, both variants have missense mutations in the C-terminus
that could be adding to the stability of the coiled-coil. Despite these findings, the exact role the
C-terminus plays in APOL1 ion channel activity and kidney disease is poorly understood. We
therefore want to determine the role of the C-terminal heptad repeat on channel formation, and
whether it is dependent on oligomerization by the putative coiled-coil.

Results:
We sought to identify the importance of the C-terminal domain on APOL1 channel
formation. Past studies have noted a potential leucine zipper motif in this region, as well as
observing C-terminal truncations causing a loss of trypanolytic and channel activity [16, 71]. The
heptad repeat within this region is defined by a leucine residue being positioned every 7th amino
acid, thus falling into the same “d” position in an alpha helix (Figure 18B). Furthermore, a
hydrophobic residue is located on the same helical face, and in this case occupies the “a”
position (Figure 18B). This strip of “knobs” (leucines) and “holes” (hydrophobic residues) can
form either dimers or oligomers, which are stabilized by van der waals forces (Figure 17).
Additionally, charged residues in the “g” and “e” positions can potentially form salt bridges,
further stabilizing the coiled-coil interaction (Fig 13).
In order to begin testing the importance of the C-terminal heptad repeat, we made
numerous site directed amino acid substitutions in this region and purified the recombinant
proteins from E. coli. The LZA rAPOL1, which replaced all four of branched chain leucines with
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the smaller, but still hydrophobic, alanine amino acid resulted in a protein that was no longer
able to lyse T. brucei 427 in vitro (Fig 14A and B). In contrast, a substitution of a cysteine (C)
residue into either the “a” position alanine-375 (A375) to cysteine or “f” position lysine-373
(K373) to cysteine had no effect on rAPOL1 trypanolytic activity (Figure 19A and B).
Furthermore, an alanine substitution with cysteine (A363C) N-terminal of the putative coiledcoil still retained lytic activity, albeit slightly less compared to G0 rAPOL1. The final rAPOL1
protein, which combines the LZA and A375C substitutions (LZA A375C), was unsurprisingly
non-trypanolytic (Figure 19A and B).
We next sought to characterize the LZA rAPOL1 channel formation in planar lipid
bilayers to uncover the loss of activity in trypanolytic assays. The LZA protein is added to the cis
chamber with a cis pH 7.4/trans pH 7.4, and no change in the current is observed as expected
(Figure 20A). When the cis chamber is acidified with 1 M HCl to pH 5.4, which typically allows
rAPOL1 to insert into the bilayer, we detect a slight increase in the macroscopic conductance.
However, neutralization of the cis chamber to pH 7.4 to open the channels results in slight
membrane instability, followed by stabilization of the current without any fold increases in ion
movement through the channel (Figure 20A). To confirm this result, we tested the LZA protein
against the G0 rAPOL1 on the same bilayer membrane. After repeating the same procedure as
above, we noticed the same result for the LZA protein; insertion at acidic pH, but no fold
increase of conductance upon neutralization (Figure 20B). An equivalent amount of G0 rAPOL1
was then added to the trans chamber, which was then acidified to allow for membrane insertion.
After waiting approximately the same amount of time, about ~30 seconds, the trans side was
neutralized (Figure 20B). Indeed, we see a large increase in the conductance of the system,
confirming a stable bilayer and confirming our previous LZA bilayer result.
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Seeing that substitution of the four leucines for alanines in the C-terminal heptad repeat
resulted in complete loss of trypanolytic activity and channel opening, we investigated the
importance of these residues further. Our goal was to generate sequential LZA rAPOL1 proteins
and discern partial loss of activity in 24-hour trypanolytic assays (Figure 21A), thus implicating
the entirety of the heptad repeat as crucial to APOL1 channel function, rather than a single
substitution causing the loss of function effect we observed with LZA rAPOL1. Substitutions
were inserted via PCR mutagenesis, and the proteins were isolated and purified from E. coli.
Interestingly, the LZA 1 protein had a significant loss of activity, with the LZA 2 and 3 rAPOL1
proteins having complete loss of lytic activity at concentrations up to 800 ng/mL. (Figure 21B).
Conversely, the LZA 4 had activity nearly identical to that of G0 rAPOL1, suggesting the Cterminal leucines have less of an impact on lytic activity than the N-terminal residues (Fig 16B).
This was further supported by the LZA 5 and 6 proteins, which still retained some activity, albeit
marginal in the case of LZA 6. (Figure 21B) However, it is unclear if these substitutions either
prevent insertion or diminish channel conductance. But based on the earlier experiments
highlighting LZA rAPOL1 can still insert upon acidification into the bilayer system, we can
deduce it is the latter (Figure 20A).
Having extensively examined all of the “d” position leucines in the heptad repeat, we
sought to test the tolerance of cysteine substitutions on different faces of the putative alpha helix.
The first substitution was targeted to position 375, and replaced an alanine predicted to occupy
the “a” position of the coiled-coil (Figure 19A). A second substitution of K373C, would insert a
cysteine on the opposite face of the helix in the “f” position (Figure 19A), and should have no
effect on the putative hydrophobic face. If both substitutions are tolerated such that they retain
both trypanolytic and channel activity, we wanted to test if small thiol reactive groups could
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inhibit either of these characteristics. Indeed, both K373C and A375C were well tolerated in
trypanolysis assays (Figure 19B), and formed significant conductances in planar lipid bilayers
after insertion and subsequent neutralization (Figure 22A and 23A). Therefore, we can conclude
A375C and K373C are fully functional proteins.
With both the A375C and K373C proteins having both trypanolytic and ion channel
activity, the next step was to test if incubation with the small, charged molecule MTSET would
inhibit or disrupt these functions. We hypothesize that the addition of the charged moiety to the
hydrophobic pocket of the coiled-coil would disrupt channel formation (“a” position; 375),
whereas a small molecule attached to the hydrophilic face (“f” position; 373) would have no
effect. To begin testing this, the A375C APOL1 was added to both sides of the bilayer chamber,
with a large molar excess of MTSET added only to the cis side (Figure 22B). After a 10-minute
incubation at pH 7.2, the cis chamber was acidified with 1 M HCl. A ~1pA increase in
conductance was observed afer ~30 seconds, suggestive of APOL1 insertion into the bilayer.
However, upon neutralization there was membrane instability, followed by no large increase in
conductance. Intriguingly, this effect mirrored what we observed for the LZA channel formation
characteristics (Fig 15A). The trans chamber was then acidified to allow for insertion of the untreated A375C, and neutralization resulted in a large conductance change confirming the A375C
protein can form functional channels and the membrane was intact (Figure 22B).
With pre-incubation of MTSET ablating channel opening of APOL1, we wanted to test
the effect on already formed channels. The A375C protein was thus added to a previously
acidified cis chamber, given satisfactory time to insert into the bilayer, and then neutralized
(Figure 22C). With a conductance of ~80pA, we added MTSET to the cis chamber at a final
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concentration of 1 mM. Over time the macroscopic conductance began to slowly decrease,
suggesting the MTSET was inhibiting the channels. To confirm this effect was specific to the cis
side, we added 1 mM MTSET to the trans chamber, and there was no observable increase in
conductance loss over time (Figure 22C). Therefore it appears the MTSET effect is cis specific,
and potentially due to disruption of the hydrophobic face of the coiled-coil.
To test if the effect of MTSET seen with the A375C protein was a specific interference
event due to targeted labeling of the cysteine residue or a non-specific interaction, we generated
the K373C mutant. The substitution of cysteine was predicted to replace the lysine in the “f”
position of the helix, and therefore have no effect on the hydrophobic pocket (Figure 17B).
Unsurprisingly, the protein retained normal lytic function in a 24-hour killing assay, and was
able to form pH-gated channels in the planar lipid bilayer (Figure 19B and 23A). When the
protein was pre-incubated with a large molar excess of MTSET before channel formation,
K373C was able to insert into the bilayer and displayed a conductance increase in response to cis
pH neutralization nearly identical to that of the untreated K373C (Figure 23A and B).
Additionally, the channels still reacted to titrations in the cis solution pH, implying they are
completely functional. We can therefore conclude the MTSET effect in specific to the A375C
protein, due to its positioning in the hydrophobic hairpin of a coiled-coil structure.
With mounting evidence to support APOL1 is indeed an oligomer as a functional
channel, we wanted to test this concept further. We hypothesized combining the G0 rAPOL1
with a non-functional variant in a 24-hour trypanoltyic assay could rescue killing. If the protein
does indeed form oligomers, having a large fold difference in non-functional to functional
protein could cause a reduction in expected lytic activity. On the other hand, increased lytic
activity could identify a dominant phenotype of the functional APOL1 and further support

67

68

APOL1 must be an oligomer as a functional channel. As the non-functional protein we chose
both the D348H and LZA proteins. The former still showed an ability to insert and generate a
small conductance in the bilayer at neutral pH, while the latter could not theoretically dimerize
and therefore interact with the G0 protein (Figure 14A and 20A). Oddly, however, an 8-or 16fold ratio of non-functional to functional APOL1 had no effect on the lytic potential of G0
APOL1 in a 24 hour assay regardless of which variant was used (Figure 24).
In order to observe oligomers of APOL1 biochemically we again turned to the A375C
protein. Utilizing the notion that disulfides form under neutral, non-reducing conditions, we
incubated the protein under different buffer pH values for 2 hours to see if dimers formed more
readily. As a control the A363C (lytic) and LZA A375C (non-lytic) proteins were first tested in
trypanolyic assays and then for ability to form disulfides under the same conditions. Keeping the
A375C protein at neutral for two hours showed no signs of disulfide formation, suggesting the
two cysteines are not located near one another under these conditions (Figure 25A). However,
acidifying for an hour followed by neutral conditions for one hour (to promote disulfide
linkages) showed a dimer band of APOL1 on a non-reducing SDS gel that was silver stained to
visualize proteins. Keeping the protein at acidic for 2 hours and only briefly neutralizing had no
indication of disulfide formation, potentially because sufficient time was not given for the
disulfide to form spontaneously (Figure 25A). Conversely, both the A363C an LZA A375C
proteins showed a slight disulfide band in all three conditions, suggesting the dimers are non
specific to the pH changes of the buffer (Figure 25A and D). Therefore, it stands to reason
acidification drives stabilization and potential oligomerization of the C-terminal heptad repeat,
and thus enables the cysteines within the coiled-coil to get close enough that the disulfides are
able to form.
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Previous work has shown that SRA binds to the C-terminus of APOL1, and is able to
prevent channel opening upon neutralization. It is then possible that this effect is due to SRA
blocking the C-terminal domain from forming a coiled-coil, and thus destabilizing the channel
and saving the parasite from APOL1-mediated lysis. To test this theory, we incubated the A375C
protein under the same conditions as before, but in the presence of a 2-fold molar excess of
rSRA. As expected, there were no dimer bands in either the 2-hour neutral or 2-hour acidic lanes
(Figure 25B). However, we did observe two dimer bands of ~90 kD (APOL1/APOL1) and
~70kD (APOL1/SRA) in the 1-hour acidic plus 1-hour neutral lane (Figure 25B). Using Jmol
pixel density analysis we concluded that the relative band intensity of the APOL1 homodimer
without SRA to be ~12% (Figure 25C), whereas in the presence of SRA, the ~90 kD band
approximated to be the homodimer was only ~2%, and the APOL1-SRA heterodimer was ~5%
(Figure 25C). Thus, SRA appears to block the formation of the artificial disulfide in the A375C
protein.

Discussion:
Here, we have extensively explored the C-terminal heptad repeat to test its role in
APOL1 channel formation. Substitution of the leucines occupying the “d” position to alanine
resulted in a protein unable to lyse T. b. brucei in vitro and incapable of forming large
conductances in planar lipid bilayers despite unaltered membrane insertion. Sequential
substitutions of the leucines caused partial loss of trypanolytic activity, with the loss of upstream
leucines having a greater loss of lytic activity than the downstream residues. Furthermore,
disruption of the putative hydrophobic strip with the positively charged MTSET thiol-reactive
group results in loss of channel opening with the functional A375C rAPOL1 protein.
Biochemical analysis of the C-terminus indicated that prior acidification is necessary for
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disulfide formation with the A375C protein, which has the cysteine located on the putative
hydrophobic face of the coiled coil. Interestingly, this reaction can be hindered by the presence
of SRA., while substitution of the four “d” position leucines also ablated disulfide formation
under the same conditions. Altogether, the data presented here indicates the C-terminus is crucial
for APOL1 channel opening, and suggestive that APOL1 forms oligomers via a coiled-coil
interaction upon acidification.
The importance of the C-terminus in APOL1 trypanolytic and channel activity has had
conflicting reports in the literature. A study first reporting APOL1 as the trypanolytic factor of
human serum reported that the terminal 343-398 residues were dispensable for activity [71].
Additionally, a group observing the channel-forming potential of APOL1 found an N-terminal
fragment from 60-235 could form anion pores in planar lipid bilayers and possessed bactericidal
activity [15]. However, recent literature studying the full-length protein points to APOL1 being a
pH-gated, cation channel in both planar lipid bilayers and large unilamellar vesicles [16, 55, 65].
Thomson and Finkelstein also observed a C-terminal amino acid truncation eliminating residues
349-398 resulted in an inability to insert into planar lipid bilayers or form channels. Considering
a single leucine to alanine substitution, which maintains hydrophobicity of the residue, in the Cterminus (LZA 1; L371A) caused a large decrease in trypanoytic, it further supports the
importance of this region. Taken together, it suggests the cation channel observed and studied
here is indeed dependent on the C-terminus, while the N-terminal fragment studied by other
groups may be a different, unidentified species.
Noting the importance of the C-terminus in regards to APOL1 channel function, we
examined if the heptad repeat motif was essential for activity. A previous study noted that
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substitution with either alanine or serine for residues (378/382/385) caused loss of lytic activity,
in agreement with our observation that the LZA rAPOL1 was unable to lyse T. b brucei 427 in
vitro or form a stable conductance in the bilayer system [71]. Furthermore, the sequential amino
acid substitutions revealed replacement of multiple leucines (LZA 2/3/6) was required for
complete loss of trypanolytic activity after a 24-hour experiment, implying cooperation of the
leucines within the channel is essential for activity rather than a single residue. Additionally,
insertion of a charged residue within the putative hydrophobic pocket by reacting the functional
A375C protein with MTSET caused loss of channel activity. Therefore, we can infer that both
hydrophobicity and “d” position leucines are necessary for APOL1 channel and trypanolytic
activity. This evidence strongly suggests the heptad repeat at the C-terminus of APOL1 indeed
forms a coiled-coil, which is dependent on these two properties, as a functional channel [126].
Looking more carefully into the trypanoltyic activity of the sequential LZA proteins gives
further insight into the APOL1 channel. Of all the sequential LZA proteins tested, we want to
highlight that the LZA 4 (L392A) protein had identical lytic activity as G0 rAPOL1. This was
unexpected; especially considering that the LZA 1 (L371A) had an IC50 nearly four-fold higher
than that of G0 rAPOL1. Interestingly, the G2 rAPOL1 has the fourth lecuine out of position due
to a two amino acid deletion (388/389), suggesting this residue is dispensable for lytic activity.
This observation is confirmed in the literature, where the G2 rAPOL1 was able to form large
conductances in the planar lipid bilayer and kill trypanosomes comparably to G0 APOL1 [16].
Additionally, another group testing truncated mutants of APOL1 found that nine amino acid
deletions in the C-terminus, which removed the L392 residue, also retained lytic activity [71].
Taken together, the entirety of the heptad repeat motif does not appear to be compulsory for
stabilization of the coiled-coil or APOL1 functionality.
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Considering the evidence presented here suggests that APOL1 forms a coiled-coil as a
channel via the C-terminus, we want to speculate on the oligomeric state of APOL1. Naturallyoccurring proteins with heptad repeats are able to form mutli-unit coiled-coils ranging from
dimers all the way to hexamers [126]. However, an earlier group demonstrated the identity of the
“d” position could strongly predict the oligomeric state of a coiled-coil [127]. Utilizing the
coiled-coil domain of the yeast transcription factor GCN4, the group revealed switching of the ad positions from isoleucine-leucine, to isoleucine-isoleucine and leucine-isoluecine exclusively
formed dimers, trimers, and tetramers, respectively. In the case of APOL1, only leucines are
observed in the “d” position of the heptad repeat, which is analogous to a specialized coiled-coil
termed a leucine zipper [128]. While we would then predict this motif to form a dimer, this
structure is classically observed with DNA-binding proteins [129]. However, it should be noted
the human voltage gated proton channel also rely on a coiled-coil for dimerization and slower
gating kinetics [130, 131]. Indeed, the C-terminal heptad repeat contains a leucine in each of the
“d” positions for the human voltage gated proton channel. So while we cannot completely rule
out a higher order oligomer, we propose APOL1 is a dimer as a functional channel.
Regarding APOL1 channel formation, the exact order of events leading to ion
conductance is unclear. To better understand the precise order of events leading to channel
formation, we looked into the alpha pore-forming proteins, which bear resemblance to APOL1
due to predicted highly alpha helical secondary structure. These pores can assemble in either the
“concerted” or “non concerted” model. In the “concerted” model, the protein binds to the
membrane and the pore fully oligomerizes prior to membrane insertion; the “non concerted”
model is defined by membrane binding and insertion either prior to or simultaneously with
oligoermerization [132]. Based on the results generated in our study, it appears APOL1 most
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likely follows the “non concerted” model of formation. This concept is supported by the LZA
rAPOL1 and A375C-MTSET bilayer experiments, in which we observed both species could
insert into the membrane but not form open channels upon neutralization. We predict these
proteins entered into the membrane as a monomer, suggesting pre-dimerization is not necessary
for insertion. We can then conjecture acidification allows for concurrent insertion of the HLH
(178-220) and dimerization of the C-terminus. At an acidic pH, protonation of the glutamates
(E201/E209/E213) in the HLH would allow for membrane insertion, while simultaneous charge
neutralization of the C-terminus (365-398; pI of ~4.4) promotes the colied-coil interaction [14].
The inability to form open channels upon neutralization could be owed to the monomer’s
inability to respond to pH changes.
We also want to comment on the mechanism by which SRA blocks APOL1-mediated
lysis of T. brucei rhodesiense. A past study observed SRA interacts with the C-terminal peptide
of APOL1 under acidic conditions, and a single amino acid substitution of N388K drastically
reduced this interaction [14]. This suggests SRA binds to the C-terminus within the heptad
repeat, the region where we predict APOL1 forms a dimer. Therefore, SRA may block
oligomerization of APOL1, preventing large cation conductances and accordingly evade
APOL1-mediated cell death. Our experiments measuring disulfide formation of A375C
confirmed this theory, in that that the presence of SRA limited the disulfide formation in the 1hour acidic/1-hour neutral condition. Additionally, Thomson and Finkelstein performed planar
lipid bilayer experiments with recombinant SRA and APOL1. Pre-incubation of the cis chamber
with SRA prior to adding G0 rAPOL1 and acidifying had no effect on APOL1 membrane
insertion. However, it did prevent channel opening after neutralization, and appeared to remove
the protein from the membrane [16]. Taken together, the above evidence strongly implies that the
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APOL1 channel is indeed an oligomer, and SRA blocks this activity by interacting with the
heptad repeat to evade trypanolysis.
APOL1 has also been linked to cytoxicity leading to kidney disease in individuals with
recent African ancestry. Currently there are several mechanisms implicated, including activation
of the inflammasome, channels at the plasma membrane leading to potassium efflux, and
opening of the mitochondrial permeability transition pore [81, 113, 133]. We propose that
regardless of the downstream effects, the formation of the dimer is the upstream initiator of cell
death. Within the same experiment, overexpression of the LZA protein in HEK293 cells showed
LDH release, an indicator of cell death, similar to that of cells that were not transfected.
Conversely, G0 APOL1 caused nearly 40% cell death in this overexpression system (Figure 26).
Hence, it stands to reason the heptad repeat in the C-terminus is involved in cell death. However,
we cannot rule out trafficking of LZA rAPOL1 to the membrane may be hindered, especially
considering the KCNQ1 cardiac potassium channel is dependent on a C-terminal leucine zipper
for correct cellular processing [134]. While we cannot discern between a lack of channel
formation, evidenced here, or disruption of an intracellular protein-protein interaction in this
system, we can indeed conclude the leucine zipper is relevant to APOL1 kidney disease.
All together, the work in this section is highly suggestive that APOL1 is indeed an
oligomer as a functional, pH gated channel. While the data presented here supports APOL1 as a
dimer, more biochemical evidence will be needed to confirm this finding. Still, it appears the
dimer is required for trypanolytic activity of T. b brucei, and SRA is able to inhibit this coiledcoil interaction. The dependency on the dimer for channel activity may also have implications
for APOL1-mediated kidney disease, and further research into the topic is required.
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Chapter 3: Investigating APOL1 Channel Topology
Introduction:
Ion channels are integral membrane proteins that allow the passage of ions from one side
of the membrane to the other. Channels typically follow a specific overall topology, with each
subunit spanning the membrane anywhere from two to seven times in order to form a channel
through the lipid bilayer [135]. An intramembrane loop often acts as the selectivity filter, and the
residues lining this region vary to allow for ion specificity by both charge and size restrictions.
For the APOL1 channel, a lot of work has gone into the mechanism of APOL1 channel
formation, yet very little is known about the channel topology. The first paper simply labeled
three of the regions as the pore-forming domain (PFD; 60-235), the membrane-addressing
domain (MAD; 250-290) and the SRA-interacting domain, and this remains the nomenclature in
the literature today [15].
Recently, groups have attempted to determine the membrane topology and number of
transmembrane domains of APOL1. In 2014, a group using PROFSec secondary structure
prediction software predicted APOL1 has three transmembrane domains as a functional channel
[14]. A biochemical approach to determining membrane topology was done by measuring the
absorbance of tryptophans after insertion of the PFD of APOL1 into a vesicle system [65]. The
authors concluded that the two transmembranes of the HLH (177-228) are able to span the
membrane under acidic conditions, but subsequent neutralization of the extracellular milleu
resulted in amino acids in the N-terminal domain to insert into the vesicles, despite there being
no evidence of hydrophobic or transmembrane domains.
Recently, an in silico approach was taken to determine APOL1 channel membrane
topology and channel structure. Utilizing the iTASSER server, they generated templates from
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numerous solved protein structures, including the Talin triple domain, yeast fatty acid synthase
and the cytotoxin MakA from Vibrio Cholera. With this approach, they determined each subunit
of APOL1 contributes five transmembrane domains to form the pore [81]. Here, we use the Jpred
4 and MEMSAT-SVM online servers to assist in the identification of the transmembrane
domains of the APOL1 channel. We then generated and purified 35 cysteine mutants of APOL1
to test membrane topology in the planar lipid bilayer system.

Results:
We performed our own in silico analysis of the full amino acid sequence of G0 APOL1
(28-398) sans the signal peptide. The nine various online prediction servers utilize various
methods to determine the secondary structure and potential transmembrane domains of the
inputted amino acid sequence. After performing this meta-analysis, a total of four unique
putative transmembrane domains were identified (Table 1). All nine servers predicted a
transmembrane domain spanning residues 175-197 (TM1), while six out of the nine software
programs identified a second putative transmembrane domain (TM2) located between amino
acids 206-226. With a short span of residues between these two regions, TM1 and TM2 form a
potential helix-loop-helix motif reminiscent of bacterial toxins. Interestingly, only the Jpred 4
server identifies a potential transmembrane domain (TM3) spanning residues 264-282, which
resides in the theoretical membrane-addressing domain (MAD). Finally, a fourth transmembrane
(TM4) is positively predicted by seven of the nine software servers, and is located in the Cterminus and thus the SRA-interacting domain (334-354) of the protein.
Based on this data, we developed a consensus model of three predictive transmembrane
domains for the APOL1 channel. Consisting of TM1, TM2 and TM4, in agreement with an
earlier result by Thomson et al. (Figure 27) [14]. However, there was no consensus
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between the extracellular or intracellular localization of the solvent accessible residues, so we
cannot comment on the channel orientation at this time. Additionally, we want to highlight the
four transmembrane and two transmembrane models predicted by Jpred 4 and MESATSVM/DAS, respectively (Figure 27). This is due to the fact that of the well-studied ion channels,
only the Ca2+ activated K+ channel has an odd number of transmembrane domains [108].
Therefore, we cannot immediately rule out the possibility of the four or two transmembrane
models.
With all three possible structure prediction models indicating numerous intracellular/trans
residues, we wanted to confirm if this was indeed the case. Therefore, we tested the cis and trans
effects of various proteases on the G0 rAPOL1 channel. After the protein was inserted into the
membrane at acidic pH 5.4 and channels opened after subsequent neutralization to pH 7.4,
proteinase K was added to the cis chamber (Figure 28). Cutting after hydrophobic residues,
proteinase K caused an approximately 50% decrease in the macroscopic conductance, but the
channel still retained pH gating functionality. After addition of proteinase K to the trans
chamber, the conductance decreased once again, demonstrating amino acids involved in ion
movement are undeniably located on the trans side of the membrane. However, we are unable to
conclude the exact number or the precise function of the residues cleaved by proteinase K.
The wide pH range of proteinase K activity, from pH 4-12, gives us the ability to test if
additional sites are accessed when pH gating the channels [136]. APOL1 was inserted into the
membrane with cis pH 5.4, forming a 4-5 pA current. A large molar excess of Proteinase K was
added to the cis chamber for a specific activity of 1.8 mAU/mL (Figure 28B). After ~3 minutes,
which should be sufficient time to cleave the ~9.3 pmol of protein, the channels were opened by
neutralization of the cis chamber to pH 7.4. This resulted in a large conductance change,
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suggesting APOL1 is protected from proteinase K activity once it has entered the membrane
(Figure 28B). However, the conductance began to immediately decrease due to the activity of
proteinase K still in the cis chamber. Thus, it would appear pH gating is not affected by
proteinase K, and additional cleavage sites are accessible due to a conformational change when
switching from acidic to neutral pH.
While proteinase K activity had no effect on pH gating, it is unclear as to its effect on
selectivity of the channel. We have previously shown in this dissertation that the channel cation
selectivity responds to cis pH, but it is unknown if the filter is inside or outside of the membrane.
If we consider cis addition of proteinase K causes a large decrease in conductance, it stands to
reason the filter could be on the extracellular side of the membrane. To test this idea, G0
rAPOL1 was added to the cis chamber and allowed to insert into the membrane at pH 5.4. After
insertion, proteinase K was allowed to cleave any accessible amino acids residues at pH 5.4,
before further digestion of the cis residues at neutral pH. After sufficient digestion, 3 M KCl was
added to the cis chamber to create an ion gradient. At this activity raio of 1.78:1 cis to trans, the
reversal potential of the system was determined to be approximately -16 mV on the cis side (data
not shown). Using the Nernst equation, the reversal potential was calculated to be -16.5 mV,
indicating the channel still appears to retain its ideal cation activity.
Having sufficiently tested the effect of proteinase K on APOL1 channel characteristics,
we wanted to test the effect of other proteases. After forming open channels, trypsin was added
to the trans chamber, but unlike proteinase K there was no effect observed on macroscopic
conductance (Figure 29). Trypsin was then added to the cis chamber, and again no effect on the
conductance was measured. This could be explained by the high specificity of trypsin compared
to that of proteinase K, in that it cuts only after arginine and lysine residues [137]. Proteinase K,
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on the other hand, cuts after hydrophobic residues, but given sufficient time can reduce proteins
to single amino acids [136]. To test that nothing was wrong with the system, pronase was added
to both the cis and trans chambers, resulting in a similar effect of that seen for proteinase K
(Figure 29).
With sufficient evidence that the channel has residues involved in channel conductance
on both faces of the membrane, we wanted to more precisely determine the membrane topology.
To accomplish this, we utilized the scanning cysteine accessibility method on the entirety of the
APOL1 protein. By introducing 35 individual cysteines at various locations into APOL1, which
does not contain any intrinsic cysteine residues, we could precisely biotin label the protein with
MPB (Figure 30 and 31). The maleimide group of the molecule reacts specifically with free
thiols at neutral pH, and is linked to a biotin moiety (Figure 31A and B). If the protein were still
trypanolytic in a 24-hour assay, it would be introduced into the bilayer system and probed with
streptavidin for effects on the overall macroscopic conductance (Figure 31C). It would be
assumed that whichever side the streptavidin was added to cause the effect was the location of
the cysteine, and repeating for each purified cysteine APOL1 protein would yield the relative
membrane topology.
To begin purifying rAPOL1 proteins, 35 primer sets were generated to introduce cysteine
substitutions throughout the APOL1 protein via PCR mutagenesis (see methods). With
significant assistance from Penny Lee, each separate substitution was purified by first
transforming the pNIC-28 plasmid containing the mutated APOL1 gene into specialized BL21DE3-RIPL cells. After isolation of the inclusion bodies, the rAPOL1 protein was purified as
detailed in Appendix 1. All cysteine proteins were then tested in a 24-hour trypanolytic assay for
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activity. Testing of the proteins revealed N-terminal cysteine mutations had minimal effect on
activity (fig 27). Conversely, substitutions within the HLH caused complete loss of function of
several proteins, defined here by less than 50% lytic activity at a final concentration of 800
ng/mL (Figure 33A), only L158C, V168C and T217C retained any activity. Within the so-called
MAD, only the L268C protein was non-functional (Figure 34A). In the C-terminal domain,
V338C and D348C caused loss of activity (Figure 35A). This was unsurprising for the D348
residue, considering it has a large role in pH gating and cation selectivity described in the first
chapter, but may suggest V338C is part of the pore as well. These results have been summarized
in Tables 2 and 3.
The proteins that retained trypanolytic activity were subsequently conjugated with MPB,
and then purified over a monomeric avidin column to remove unlabeled protein. After removal
of free MPB and free biotin in the elution buffer with a spin column, the labeled protein was
tested in a 24-hour assay. Interestingly, none of the N-terminal cysteine substitutions lost
complete lytic activity when tagged with the MPB moiety (Figure 32B), strongly suggesting this
region may not have any importance to the lytic activity of APOL1. However, tagging APOL1
from L158C to I228C with MPB resulted in a non-functional protein, highlighting the
importance of this region for trypanolytic activity (Fig 28B). Within the MAD, residues, L248C,
L258C and L268C were all non-functional after tagging with MPB, hinting at an important
domain in this region (Figure 34B). Additionally, MPB-H298C showed a lack of trypanolytic
activity; however the reasoning is unclear. In the C-terminus, only the V346C protein lost
functionality in this assay (Figure 35). These findings have been summarized in Tables 2 and 3.
To ensure we had efficient labeling of the cysteine proteins with MPB, we had to find a
way to visualize the conjugation. Therefore, we briefly incubated the MPB-APOL1 proteins with
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streptavidin prior to an SDS-PAGE gel under both reducing and non-reducing conditions. The
streptavidin-biotin interaction has a Kd of approximately 10-15 M, and is one of the strongest noncovalent interactions known [138]. Furthermore, the interaction can withstand up to 2% SDS, so
any MPB tagged APOL1 would see a large shift in migration due to the addition of the ~53 kD
Streptavidin tetramer [139]. Using ~0.94 uM APOL1 incubated briefly with 9.5 uM streptavidin,
the samples were run on a Tris-glycine anyKD Bio rad gel. After coomassie staining, only a
rAPOLl-sized band appeared in the G0 rAPOL1 lane, which does not have a cysteine or MPB
tag (Figure 36A and B). On the other hand, all the tagged proteins had either faint or undetectable ~43 kD bands, implicating efficient labeling and purification of the MPB-APOL1
proteins both with and without reducing conditions (Figure 36A and B).
Now having confirmed which proteins are no longer trypanolytic and we had uniform
labeling of the cysteine APOL1 proteins, we began testing them in the bilayer system. With
streptavidin being a 52.9 kD protein (tetramer), we assumed it could block the steady-state
conductance by either sterically blocking the pore or causing a deleterious conformational
change due to its size. To avoid testing any non-conducting protein, only APOL1 cysteine
mutants that retained lytic activity were chosen, because we expected them to still form channels
in the bilayer system. We began with the viable MPB-V244C protein, which indeed generated a
large conductance upon acidification and subsequent neutralization (Figure 37) While addition of
streptavidin (~10-fold molar excess) to the trans chamber had no effect on the channel
conductance, adding the same concentration of streptavidin to the cis chamber caused a large and
rapid decrease in conductance (Fig 32). Therefore, we strongly infer the cysteine at position 244
is on the cis/extracellular side of the membrane.
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We next tested the MPB-R305C protein, which is predicted to reside on the trans side of
the membrane in both topology models. Expectedly, based on our trypanolytic assay results, the
protein formed a large and stable conductance at neutral pH after insertion at pH 5.6 (Figure 38).
However, streptavidin had no effect on the conductance of the system, even when adding 20-fold
molar excess compared to MPB-R305C protein (190 nM Streptavidin compared to 9.4 nM
APOL1) to both the cis and trans solutions. Based on this, we can infer the streptavidin was
either unable to access the MPB residue because it was either not exposed to the aqueous buffer
or the residue is located in a region not vital for channel function. On the other hand, streptavidin
had a significant effect on the MPB-K373C channel when added to the cis chamber, but not the
trans (Figure 39). Therefore, we can conclude this residue is on the cis/extracellular side of the
bilayer as well. We went on and examined numerous other MPB-APOL1 proteins in the bilayer,
but only the A108C showed any effect after streptavidin addition (Summary of Results in Table
4).
Based on the evidence here, the two (MEMSAT-SVM) and three (consensus)
transmembrane models predicted by in silico analysis seem unlikely. However, we are unable to
confirm the four transmembrane model at this time, although our data does support it. Therefore,
we used Protter to generate a topology model and the effect of each cysteine substitution on each
position (Figure 40). A green circle indicates no effect on lytic activity with or without MPB, so
these regions may not have significant impact on channel formation. An orange circle indicates
the cysteine substitution produced a lytic protein, but tagging with MPB caused complete loss of
activity. A red circle indicates just a cysteine substitution cause loss of functionality in the 24hour assay, and therefore must be in a region critical to APOL1 function.
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Discussion:
In this section, we assess the membrane topology of the APOL1 channel. Secondary
structure prediction servers Jpred 4 and MEMSAT-SVM estimated APOL1 had either four or
two transmembrane domains, respectively. While a consensus of nine different transmembrane
prediction servers identified three putative transmembrane domains. We next assessed if APOL1
channels in the planar lipid bilayer system were affected by protease digestion on either the cis or
trans side of the membrane. Indeed, proteinase K and pronase caused significant reductions in
macroscopic conductance after addition to the cis or trans chambers, signifying the channel must
have residues on the extracellular and intracellular sides. Interestingly, trypsin had no effect on
APOL1 channel conductance possibly due to its inability to cleave between any residues in the
HLH of APOL1. To better confirm membrane topology, we generated and purified 35 different
cysteine substitutions of APOL1 to employ the scanning cysteine accessibility method. Testing
each mutant with and without MPB labeling in 24-hour Trypanolytic assays identified residues
that retained functionality, which could then be tested in the planar lipid bilayer system. Of all
the proteins tested, addition of streptavidin to the cis chamber, but not the trans, was able to
significantly lower conductance of the only MPB-A108C, V244C and K373C proteins. Thus, it
appears these residues are located on the extracellular side of the membrane, supporting a four
transmembrane model of APOL1.
An in silico approach was utilized to identify potential transmembrane models we could
begin to test in vitro. The first sever we employed, Jpred 4, predicts four transmembrane
domains; an N-terminal HLH (residues 177-228) forms TM 1 and 2, while the third
transmembrane is at residues 264-282. The fourth transmembrane is predicted to be from 335-
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356, which is most likely the pore-lining region we examined earlier. While we only were able to
correctly identify three residues that were located on the extracellular side of the membrane, they
all confer with the Jpred 4 prediction. Additionally, each of the four predicted transmembrane
domains were intolerant to cysteine substitution (red circle), which may further support this
model (Figure 40). Assuming this model is correct, the APOL1 channel could have a similar
conformation to that of the human voltage proton channel (HVCN1) [140]. Notably, the HVCN1
channel has four transmembrane domains and a C-terminal heptad repeat allowing for channel
dimerization. This alone makes it a great candidate as a similar protein for future modeling, not
to mention the channel relies on an aspartic acid as the selectivity filter [141]. But without
further evidence of residues located on the trans portion of the membrane in the bilayer system,
we cannot confirm this suspicion.
The second prediction software, MEMSAT-SVM predicted regions 177-197 and 335-356
as pore lining transmembranes. Interestingly, these domains map to TM1 and TM4 of the Jpred 4
server, and data from Chapter 1 supports that the residues from 335-356 contribute to the channel
selectivity. However, the data presented here seem to demonstrate the overall model incorrect. A
large portion of the protein was predicted to be on the trans side of the membrane, including the
V244 residue, which we determined to be exposed to the cis solution. Regarding other prediction
models, a paper published in 2014 predicted APOL1 had three transmembranes using the
PROFSec online software [14]. We know this cannot be possible because the K373C residue is
extracellular (Figure 39), and only three transmembranes would position the residue on the
cytoplasmic side. However, it is interesting to note that all three different software programs
predicted TMs at regions 177-197 and 335-356, althoug it is most likely due to the high degree
of hydrophobic residues in these regions. Another possibility for the overall channel topology not
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predicted by software is that only the HLH of APOL1 inserts into the membrane. This overall
structure would be similar to the Salmonella enterica CorA channel, which has a helix loop helix
that inserts into the membrane and the remainder of the channel is found in the extracellular
milleu [142]. Considering MPB conjugated to APOL1 cysteine groups in the HLH region caused
complete loss of activity, we suspect this region may indeed insert into the membrane. If the
remainder of the protein was then not in the membrane, this would agree with our assessment
that residues A108, V244 and K373 are all on the extracellular side of the membrane.
Additionally, the CorA channels have a ring of aspartic acid residues that control selectivity of
the divalent cations [142]. But this region exists outside of the membrane, and proteinase K did
not affect APOL1 selectivity. If the selectivity filter was removed, we should have seen a change
in the reversal potential toward anion selectivity.
Therefore, we speculated if it is possible the residues from 335-356 form an
intramembrane loop similar to the inward rectifying potassium channels [143]. For this family of
channels, each subunit contributes two transmembranes that form the channel through the
membrane and a pore loop that acts as the selectivity filter. For APOL1, the HLH would supply
the transmembrane portion, while domain from 335-356 would act as the selectivity filter. The
topology would satisfy the cis location of the A108, V244 and K373 residues, and allow for
asparate-348 to be in the membrane and protected from proteases. However, it should be noted
that transmembrane domains often directly flank the intramembrane loop in the major ion
channel families [144]. Therefore, it seems unlikely APOL1 assumes this conformation, but it is
possible the channel has a structure unprecedented in the literature.
Other groups attempting to determine the membrane topology and structure have had
inconclusive results in the literature. A strictly in silico analysis of APOL1 determined the
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protein has five transmembrane domains [81]. Interestingly, they predicted the HLH of APOL1
(171-221) as TM2 and TM3, with an N-terminal TM1 spanning residues 35-64. However, we do
not have any data to support this observation, since probing this region with streptavidin in the
bilayer had no effect on channel conductance. The fourth predicted transmembrane is roughly
near our observed pore-lining region we focused on earlier, but they did not observe the D348
residue was in the pore [81]. Additionally, they predicted the C-terminal coiled-coil is in the
membrane, which is unlikely because this region both binds to SRA and the MPB labeled K373C
within this region is accessible by the large streptavidin molecule. They also propose a pH-gating
residue E355, characterized by Russell Thomson (unpublished) to be near the trans side of the
membrane, which would prevent the amino acid from responding to changes in cis pH. We
therefore conclude the model they have published does not accurately depict the APOL1
channel.
Curiously, trypsin appears unable to alter the macroscopic conductance of APOL1
channels once in the membrane. Addition of trypsin to both chambers had no effect, while
pronase quickly and significantly reduced channel conductance in the same experiment. Because
trypsin only cuts after arginine and lysine residues, we would predict they are either inaccessible
because they are either buried within the membrane or the core of the quaternary protein
structure. Looking at the protein sequence, there are numerous predicted cut sites on the putative
extracellular and intracellular regions. We have tested that trypsin can indeed hydrolyze APOL1
when added to soluble protein (data not shown), so this non-effect must be intrinsic to the
channel itself. Therefore, more information is needed before any more conclusions can be drawn.
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Summary

In this thesis, we have thoroughly examined the APOL1 channel using a combination of
site directed mutagenesis, in vitro trypanolytic assays and planar lipid bilayers. Prior to the work
presented here, the pore-forming domain of APOL1 was understood to be in the N-terminal
domain, and the C-terminus was thought to be dispensable for both channel and trypanolytic
activity. Rather, our data conclude the C-terminus is required for multimerization by way of a
coiled-coil to form the functional channel. Additionally, the pore lining region and selectivity
filter, aspartate-348, reside in the C-terminal domain. We also have preliminary data suggesting
the channel is a four pass transmembrane protein, with a N-terminal hairpin motif crucial to
membrane insertion. Taken together, identification of these structural domains will assist to
better understanding the mechanism behind APOL1-mediated cytotoxicity leading to kidney
disease.
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Appendix 1 – Purification of recombinant APOL1 from E. coli

Prepare all solutions using ultrapure water and analytical grade reagents. All steps should be
carried out at room temperature unless otherwise noted. Diligently follow all waste disposal
regulations when disposing of waste materials.

Buffer solutions
1. Lysis buffer: 50mM Tris-HCl, 1mM EDTA, pH 8.0. Weigh 3.03g of Tris base and add to
400mL of DI water in a 500mL graduate cylinder. Add 1mL of 0.5M EDTA, mix well, and pH
solution to 8.0. Make up to 500mL with DI water. Can be stored at room temperature.
2. 10% sodium deoxycholate: Add 0.3mg of powdered sodium deoxycholate to 2mL of DI water
in a 15mL tube. Vortex to mix, then fill to 3mL and vortex again. Solution must be made fresh
and cannot be stored for subsequent purifications.
3. 1:5 diluted lysis buffer: Add 100mL of lysis buffer to 400mL of DI water in a graduated
cylinder and mix well. Can be stored at room temperature.
4. 10% Zwittergent 3-14: Add 4g of powdered detergent to 30mL of DI water in a 50mL falcon
tube. Vortex to mix, and fill to 40mL. Zwittergent solution can be stored at 4°C. (see Note 1)
5. 10% Triton X-100: 10% solution in DI water (see Note 2)
6. Zwittergent running buffer: 50mM Tris-HCl, 150mM NaCl, 0.5% Zwittergent 3-14, pH 8.6.
Weigh 3.03g of Tris-Base and 4.4g of NaCl. Add to 400mL of DI water in a graduated cylinder.
Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L. Sterilize with a 0.22um filter,
and then degas under vacuum for ~20 minutes. Carefully add 2.5g of Zwittergent 3-14, and stir
gently until all detergent has dissolved into solution. (see Note 1)
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7. Wash buffer: 50mM Tris-HCl, pH 8.6, 150mM NaCl, 10 mM Imidazole, 0.5% Zwittergent 314. Weigh 3.03g of Tris-Base, 4.4g of NaCl, and 340mg of Imidazole. Add to 400mL of DI
water in a graduated cylinder. Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L.
Sterilize with a 0.22um filter, then add 2.5g of Zwittergent 3-14, and stir gently until all
detergent has dissolved into solution. (see Note 1)
8. Elution buffer: 50mM Tris-HCl pH 8.6, 150mM NaCl, 500mM Imidazole, 0.5% Zwittergent
3-14. Weigh 3.03g of Tris-Base, 4.4g of NaCl, and 17.02g of Imidazole. Add to 400mL of DI
water in a graduated cylinder. Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L.
Sterilize with a 0.22um filter, then add 2.5g of Zwittergent 3-14, and stir gently until all
detergent has dissolved into solution. (see Note 1)
9. n-Dodecyl β-D-maltoside (DDM) running buffer: 50mM Tris-HCl, 150mM NaCl, 0.05%
DDM, pH 8.6. Weigh 3.03g of Tris-Base and 4.4g of NaCl. Add to 400mL of DI water in a
graduated cylinder. Mix well, pH to 8.6 with 10M HCl, and bring volume up to 0.5L. Sterilize
with a 0.22um filter, and then degas under vacuum for ~20 minutes. Carefully add 0.25g of
DDM, and stir gently until all detergent has dissolved into solution. (see Note 1)

Equipment
1: 37°C water bath.
2: Temperature controlled orbital shaker
3: Sonic Dismembrator apparatus with microtip probe
4: Sorvall RC-5C Plus Centrifuge (or comparable centrifuge)
5: Sorvall GSA 6 place rotor (or comparable rotor)
6: Sorvall SS-34 rotor (or comparable rotor)
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7: Beckman Coulter Type 60 Ti Fixed-Angle Titanium Rotor (or comparable rotor)
8: Polycarbonate bottle with cap assembly 25 x 89mm (Cat# 355618)
9: Fast-performance liquid chromatography apparatus.
10: GE HiLoad 16/600 Superdex 200 pg size exclusion column (or comparable column)
11: GE HisTrap HP protein purification column (Cat# 17524701)
12: Amicon Ultra-15 Centrifugal Filters 10,000 Dalton molecular weight cutoff (Fisher Cat#
UFC901024).
Transformation of bacteria with APOL1 plasmid
Day 1
1. Bacterial expression cells: Add 10-50ng of purified pNIC plasmid containing the APOL1
coding sequence to 50uL of Bl21-DE3-RIPL cells under sterile conditions in a 13mL polystyrene
tube. Flick gently to mix, then let sit on ice for 30 minutes. (see Note 3)
2. Heat shock for 23 seconds at 42*C and place back on ice for 4 minutes. Add 500uL of prewarmed LB media to tube and shake for 1 hour at 37*C at 300rpm.
3. Plate 500uL of bacterial culture on Luria Bertani agar supplemented with kanamycin and
incubate overnight at 37*C.
Bacterial Growth and Protein Expression
Day 2
1. Prepare 200mL of Overnight Express Growth media in a 500mL bottle and microwave with
the cap loose until a slight boil to sterilize. Let cool, and add Kanamycin (100ug/mL) and
Chloramphenicol (34ug/mL) and mix well. Transfer 100mL of media into a 1L Erlenmeyer
flasks under sterile conditions.
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2. Examining the plates from yesterday, select 1-5 colonies and add to the flask under sterile
conditions. Let shake for 16-18 hours overnight at 37*C at 300rpm. There is no need for addition
of IPTG with this protocol. (see Note 4)

3.2.3.Isolation of Inclusion Bodies
Day 3
1. Centrifuge the bacterial millieau at 6000 x g for 15 minutes in a GSA rotor at 4*C.
2. On ice, resuspend in 18 mL of lysis buffer and transfer to an SS34 tube (rounded cylinder).
Add 10uL 1 M DTT and 50uL 200 mM PMSF. Lyse cells via microtip sonication using a 2
second pulse at a 40% duty cycle set to the microtip limit. Sonicate on ice for 1 minute, then let
stand on ice for 1 minute. Repeat three times. (see Note 5)
3. At room temperature, while stirring, add 20uL of 5mg/mL DNase1, 20uL 5 mg/mL RNase1,
and 100uL 50 mg/mL lysozyme. Stir for 45 minutes. Then add 70uL 1M MgCl2 and 40uL 1 M
CaCl2 and stir for 30 minutes. Finally, add 1mL 10% Triton X-100 and 1 mL 10% sodium
deoxycholate (make fresh) and stir for 1 hour.
4. Remove stir bars, and pellet at 26,000 x g (14.8k rpm in SS34 or F21S-8x50Y) for 30 minutes.
5. Discard supernatant and resuspend pellet in 9 mL lysis buffer. While stirring, add 1 mL 10%
Triton X-100 and 0.2 mL 5 M NaCl and stir for 30 minutes.
6. Pellet at 17050 x g (12,000 rpm) for 30 minutes in an SS34 rotor.
7. Discard supernatant and resuspend pellet in 10 mL lysis buffer. While stirring, add 0.2 mL 5
M NaCl. Put sample(s) back on ice, remove stir bars, and repeat sonication according to the
procedure in step 4.
[At this point, sample(s) can be stored overnight at 4*C] (see Note 6)
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8. Repeat centrifugation according to step 11.
9. Discard supernatant and resuspend pellet in 10 mL of 1:5 diluted lysis buffer.
10. Repeat centrifugation according to step 11.

Extraction of rAPOL1 from inclusion bodies
Day 3
1. Discard supernatant and resuspend pellet in 8 ml DI water. Sonicate for a continuous ~10
seconds to disperse. While stirring, add 2 mL 10% Zwittergent 3-14. Slowly add 100 λ 1 M
NaOH (see Note 7). Wait 1 minute, and add 300 λ 5 M NaCl. Wait 1 minute, and slowly add 150
λ 1 M Tris-HCl pH 7.4. Stir for 15-30 minutes. (see Note 8)
2. Ultracentrifuge at 45,000 rpm (207,870 x g) for 45 minutes in a Ti70 rotor. Filter supernatant
using a 0.45 micron filter. (see Note 9)
[At this point, sample(s) can be stored overnight at 4*C] (see Note 10)

Fast Protein Liquid Chromatography
Day 4
1. Concentrate sample down to ~5mL with a centrifugal filter unit. The MW cutoff of the filter
should be 10,000 Daltons to ensure rAPOL1 (~43kDa) remains in the concentrated portion.
Optional. (ideal if highly pure yields are required). Concentrate sample down further to ~2mL.
Load the sample onto Superdex 200 16/600 column that has been equilibrated with Zwittergent
running buffer. With the flow set to 1mL/min, collect 1mL fractions and keep tubes 45-80.
APOL1 should elute around fraction ~65mL (see Note 11)
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Optional. Run SDS-PAGE of the fractions corresponding to the anticipated APOL1 peak, and 34 fractions before and after. Add 1uL of each fraction to 19uL of 2X laemelli sample buffer.
Load 15uL per lane and run at 150V. Coomassie stain and collect fractions with ideal ratios of
rAPOL1 to contaminating bands. Collect no more than 5 fractions (Note 12).
2. Load ≤5mL of sample to a 1mL His-Trap column. Program for a 1mL/min flow rate and load
sample onto the column. Wash column with 15 CV of wash buffer, then increase concentration
of elution buffer from 0% to 60% over 20mL. The rAPOL1 should elute during the gradient (see
Note 13). After the gradient, clean the column with 5mL of 100% elution buffer and then
equilibrate with 5mL of wash buffer. Collect 1mL fractions, beginning with the unbound fraction
that immediately elutes up until the cleaning step.
3. Run SDS-PAGE of the fractions corresponding to the anticipated APOL1 peak, and 3-4
fractions before and after. Add 1uL of each fraction to 19uL of 2X laemelli sample buffer. Load
15uL per lane, and run at 150V. Coomassie stain and collect fractions with ideal ratios of
rAPOL1 to contaminating bands. Collect no more than 5 fractions (Note 12).
4. Concentrate sample down to ~2mL with a centrifugal filter unit. The MW cutoff of the filter
should be 10,000 Daltons to ensure rAPOL1(~43 kDa) remains in the concentrated portion..
5. Using an equilibrated Superdex 200 16/600 column with DDM running buffer (see Note 14),
load sample into an FPLC. Using DDM running buffer, flow at 1mL/min, collect 1mL fractions,
and keep fractions 45-80mL. APOL1 should elute around fraction ~67mL.
6. Run SDS-PAGE of the fractions corresponding to the anticipated APOL1 peak, and 3-4
fractions before and after. Add 1uL of each fraction to 19uL of 2X laemelli sample buffer. Load
15uL per lane, and run at 150V. Coomassie stain and collect fractions with ideal ratios of
rAPOL1 to contaminating bands (Note 12).
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7. Pool 2-3 fractions with ideal ratios of rAPOL1 to contaminant bands. Mix gently by flicking
or slow pipetting up and down. Aliquot into ~100uL fractions, and flash freeze with liquid
nitrogen before storage at -80*C.
Notes
1. Wear a mask and goggles when weighing out either Zwittergent 3-14 or DDM. Both
detergents can be upper respiratory or eye irritants.
2. Surfact-Amps Triton X-100 is purchased from Thermo Scientific (Product #28314).
3. The rAPOL1 coding sequence contains a N-terminal 6X-His-Tag followed by a TEV cleavage
site. The tag allows for metal affinity purification, but can be cleaved off before beginning
experiments.
4. In the event of a poor transformation efficiency, only one colony may be used for inoculation.
However, several colonies help to ensure high bacterial growth and turbidity, along with high
protein yields.
5. When working with two tubes, both can be brought to sonication simultaneously. While one
tube is being sonicated, the other can be standing. However, you must clean the microtip
between sonicating if two different proteins are being purified at once.
6. If time is a concern, the purification can be paused here until the following day. But note that
storage overnight may cause proteolysis of rAPOL1 that is difficult to remove in subsequent
steps. For high purity yields, it is best to continue up until step 17.
7. On occasion, the solution will not go entirely clear at this point. Either there was too much
rAPOL1 recovered, or the inclusion bodies were not solubilized because pH 12 was not reached.
Check the pH of your solution if this is the case.
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8. Adding the 1M Tris-HCl too quickly may cause the rAPOL1 to precipitate and fall out of
solution. Slowly adding and allowing the Tris-HCl to bring the pH down in a controlled manner
will yield the highest amount of solubilized rAPOL1.
9. A Ti60 rotor may also be used.
10. It is best to pause the purification here. However, the remaining steps must be completed the
following day for optimal purity and yield.
11. If running this additional purification step, it is important to equilibrate the column overnight
from day 2 to day 3. This will save time on day 4. Run 2 column volumes of DDM size buffer
through the column at 0.4mL/min.
12. The lower, contaminating bands are often APOL1 that has been degraded by proteases during
the purification process. They are difficult to remove, and every precaution must be made when
selecting fractions to avoid them. For high purity yields, it is best to choose only 1-2 ideal
fractions rather than 4-5. Ideal fractions will have the highest ratio of full length rAPOL1 to
contaminating bands.
13. Often, there will be a double peak during the gradient. The second peak contains rAPOL1
aggregates that require additional imidazole to remove from the His-column. Try to avoid
collecting and pooling any of these fractions before loading onto the final sizing column.
14. If running the optional Zwittergent sizing column, the column must be equilibrated before
beginning step 19. Run 2 column volumes of DDM running buffer through the column at
1mL/min. If not performing the optional sizing step, the column may be equilibrated overnight
with DDM running buffer between days 2 and 3 at a rate of 0.4mL/min.
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